The Tyranny of Merit: what’s become of the common good? – The London School of Economics and Political Science

Join us for this online public event with Michael Sandel who will be discussing his latest book,The Tyranny of Merit: What's Become of the Common Good?

In this new bookSandel argues that to overcome the polarised politics of our time, we must rethink the attitudes toward success and failure that have accompanied globalisation and rising inequality. Sandel highlights the hubris a meritocracy generates among the winners and the harsh judgement it imposes on those left behind. He offers an alternative way of thinking about success - more attentive to the role of luck in human affairs, more conducive to an ethic of humility, and more hospitable to a politics of the common good.

Michael Sandelteaches political philosophy at Harvard University. His writingson justice, ethics, democracy, and markets--have been translated into 27 languages. His course Justice is the first Harvard course to be made freely available online and on television. It has been viewed by tens of millions of people around the world, including in China, where Sandel was named the most influential foreign figure of the year. (China Newsweek)

Sandels books relate enduring themes of political philosophy to the most vexing moral and civic questions of our time. They includeWhat Money Cant Buy: The Moral Limits of Markets;Justice: Whats the Right Thing to Do?; The Case against Perfection: Ethics in the Age of Genetic Engineering; Public Philosophy: Essays on Morality in Politics; Democracys Discontent: America in Search of a Public Philosophy; andLiberalism and the Limits of Justice.

You can order the book,The Tyranny of Merit: What's Become of the Common Good?, (UK delivery only) from our official LSE Events independent book shop,Pages of Hackney.

Andrs Velasco (@AndresVelasco) is Professor of Public Policy and Dean of the School of Public Policy at the London School of Economics and Political Science.

TheSchool of Public Policy(@LSEPublicPolicy) is an international community where ideas and practice meet. Our approach creates professionals with the ability to analyse, understand and resolve the challenges of contemporary governance.

Twitter Hashtag for this event:#LSESandel

View post:

The Tyranny of Merit: what's become of the common good? - The London School of Economics and Political Science

Draper to Build on its Biosecurity Tool Development for IARPA – Yahoo Finance

The Office of the Director of National Intelligence has contracted with Draper to develop new kinds of detection systems that can identify whether engineered organisms have been created from natural organisms.

CAMBRIDGE, Mass., July 28, 2020 /PRNewswire-PRWeb/ --Advances in gene editing technology and improved access via the web have substantially increased the prevalence of engineered organisms in our world. Benefits range from pest-free crops to reduction in the spread of infectious diseases, but along with these advantages comes a need to identify good bioengineering from the kind that might pose a threat.

To address this challenge, the Office of the Director of National Intelligence (ODNI) has contracted with Draper to develop new kinds of detection systems that can identify whether engineered organisms have been created from natural organisms. Officials at ODNI's Intelligence Advanced Research Projects Activity (IARPA) have awarded Draper a two-year Phase 2 contract under its Finding Engineering-Linked Indicators (FELIX) program, for a total contract value worth $7.8 million.

The award calls for Draper to continue development of two distinct lab-based genetic tests, custom bioinformatics pipelines that contextualize DNA sequencing data, and miniaturized microarray hardware with a specialized design. The devicesmaller than a postage stampallows multiple rounds of genetic tests on any organism, from a broad variety of sources including soil and water. Potential applications include biothreat detection, environmental monitoring and food inspection.

The microarray can be equipped with up to 10,000 surface probes to help identify genetic engineering. The device and associated lab methods combined are sensitive enough to pick out a ratio of a single engineered organism against a complex environmental background containing millions of natural organismsa signal-to-noise ratio that is a significant improvement over current methods.

Kirsty McFarland, molecular microbiologist and Principal Investigator on Draper's FELIX program, says the technologies under development will be able to detect genetic signatures that are not accessible with current technologies. "Current methods for detecting engineered organisms, in soil for example, read only a subset of all the genetic material that's present in the sample, typically through next-generation sequencing. That process inherently misses information and does not reveal important genetic context," she said. She noted that one gram of soil may contain up to one billion microbial genomes.

To accompany each genetic identification system, Draper also developed two custom bioinformatics tools, which include a computational pipeline and visual dashboard that convert lab data into actionable intelligence that users can see on a computer screen.

Draper's FELIX contract is the result of close collaboration between the Synthetic Biology group and Draper's Special Programs Office.

Draper At Draper, we believe exciting things happen when new capabilities are imagined and created. Whether formulating a concept and developing each component to achieve a field-ready prototype or combining existing technologies in new ways, Draper engineers apply multidisciplinary approaches that deliver new capabilities to customers. As a not-for-profit engineering innovation company, Draper focuses on the design, development and deployment of advanced technological solutions for the world's most challenging and important problems. We provide engineering solutions directly to government, industry and academia; work on teams as prime contractor or subcontractor; and participate as a collaborator in consortia. We provide unbiased assessments of technology or systems designed or recommended by other organizationscustom designed, as well as commercial-off-the-shelf. http://www.draper.com

SOURCE Draper

Read the original:

Draper to Build on its Biosecurity Tool Development for IARPA - Yahoo Finance

Halo Infinite should close the ring that is Master Chief and Cortana’s saga – GamesRadar+

Halo Infinite is coming and with it should be the end of Master Chief's 20-year story.

It certainly seems like 343 Industries is teeing Halo Infinite up to be the final chapter in the epic saga that is John-117. The trailer that debuted at the Xbox Games Showcase ends with Chief coming face-to-face with a Banished leader whose monologue implies the Chief's demise: "But here you now stand. This is my last fight. A true test of legends, our story will outlive us both. Set a fire in your heart, Spartan. Bare your fangs, fight hard, die well."

With the news that Halo Infinite is meant to be the last standalone Halo title for a decade, there's nothing left for 343 to do except to kill their darling or in this case, their Master. The blatant throwback to Halo: Combat Evolved in the Halo Infinite box art and the game's nostalgic, sunny graphics hammers home the idea that Halo Infinite will close the loop that is the Halo saga. It's a narrative Halo ring, and this is the final piece.

Here's how all roads point to Halo Infinite closing the door forever on Master Chief, Cortana, and the Halo universe as we know it, and why that's a good thing.

While Halo lore is far more complicated than the gameplay would have you think, it's clear that the epic story has been funnelling us towards a logical conclusion. Let's recap, as it can get a bit convoluted.

Long before the events of Halo: Reach, humans were an advanced, spacefaring species in the running to obtain the Mantle of Responsibility. The Mantle is an ideology before it is an object, the creation of the Precursors (an ancient species responsible for genetically engineering many of the races in the galaxy). It represents the obligation of the most advanced race to protect lesser life forms in the galaxy but the Forerunners, another alien race, believed they were the rightful inheritors of the Mantle, and began a long war that led to them forcing humans to live in a pre-technological state on a planet known as Earth.

The term "Reclaimer" is important here it's used to refer to the species chosen to inherit the Mantle in particular, it refers to humans who carry a special genetic code written in by a Forerunner known as the Librarian. Reclaimers can activate Forerunner technology it's why Master Chief comes damn near close to activating the ring in Halo: Combat Evolved, and why he seems to know his way around the tech despite never having encountered it before. It's also why the Covenant have to kidnap humans to activate Forerunner tech despite believing they deserve the mantle, none of the Covenant races are Reclaimers. Sucks to suck.

The genetic code that Chief contains is also responsible for the creation of other SPARTANs and Cortana's creation - the Librarian planted seeds that led to technological advances like the SPARTAN program and Smart AI. This speaks to the larger picture of the ties that bind Chief and Cortana.

Sacrifice is a common theme in the Halo franchise, though the ultimate sacrifice (giving one's life) has thus far been reserved for characters who aren't Master Chief and Cortana though not for their lack of trying.

In Halo: Reach, every member of Noble Team (save one) sacrifices themselves to ensure humanity can stand against the Covenant. At the end of Halo 3, it appears Chief has sacrificed himself to save humanity, although he obviously ends up surviving. At the end of Halo 4, you control Chief as he desperately claws his way to a nuclear warhead that he detonates with his hands to save humanity. Again, Chief doesn't die, despite being centimeters away from a nuclear explosion - because Cortana sacrifices herself to save him.

By Halo 5, it's clear that Cortana is still alive, though driven to madness by rampancy (a sort of deterioration that advanced AI suffer after being online for more than seven years"), and determined to get her hands on the Mantle of Responsibility, which she claims belongs to AI.

For Halo: Infinite to narratively and thematically close the Halo loop, Chief should sacrifice himself to stop the Banished (and likely Cortana and the Created, a faction of rogue artificial intelligence she founded). But there's arguably an even bigger sacrifice, in John's future Cortana herself, the closest thing this tragic figure has had to a loved one since his brief childhood.

And that may very well be the core of this Halo epic. Master Chief and Cortana's relationship, brought together by destiny, by the genetic gifts bestowed upon humanity by the Precursors.

"We go together," Chief tells Cortana at the end of Halo 4. It's a simple statement that profoundly states his feelings for her. After she sacrifices herself for Chief, a montage plays of their interactions across the series, hammering home the notion that this bond goes beyond a soldier tasked with protecting an AI. She is, after all, the only real thing that gives Chief pathos in the entire series, and that's thanks to 343 deciding to lean into that relationship when they took the Halo helm.

Before that, Chief is merely a faceless super soldier with a pretty solid moral compass, one-lining his way through a franchise in order to save the world and his snarky computer lady. Cortana and Chief are the beating heart of the Halo franchise but I think it's time for that heart to stop.

With the back-to-back fake-outs of Halo 3 and Halo 4, the stage is set for Chief to make the ultimate sacrifice. Cortana is still alive at the end of Halo 5, after having brutally betrayed him in order to continue on her rampage to get her hands on the Mantle. As the Banished leader said in the Halo Infinite trailer, it is indeed time for John-117 to "set a fire" in his heart in order to "die well." But not before he takes Cortana with him.

See the rest here:

Halo Infinite should close the ring that is Master Chief and Cortana's saga - GamesRadar+

Where Did COVID-19 Really Come From? – besacenter.org

Wuhan Institute of Virology main entrance, Wuhan City, Hubei province, China, image via Wikimedia Commons

BESA Center Perspectives Paper No. 1,664, July 28, 2020

EXECUTIVE SUMMARY: The questions of the true genomic origin as well as the direct source of the initial SARS-CoV-2 strain that infected Patient Zero in China, an event that ultimately unleashed COVID-19 on the world to devastating effect, are hotly debated and highly consequential. Both science and intelligence will contribute to uncovering the evidence needed to answer these questions conclusively.

Behind the great challenge of how to deal with the global COVID-19 pandemic are the questions of the viruss true genomic origin and direct source. These questions will likely be answered through synergies between science and intelligence, the combined findings of which will ultimately converge into a critical mass of evidence.

SARS-CoV-2 is the strain of coronavirus that causes COVID-19. According to unofficial reports and taking into account the viruss incubation period, Patient Zero was apparently infected in Wuhan, China in October or November of 2019. However, it was not until December 31, 2019 that the Wuhan Municipal Health Commission issued an alert that there was a cluster of cases of viral pneumonia in Wuhan. At the time, the initial source of the virus was said to have been an unidentified infected animal from the Wuhan wet market. This claim was later abandoned by China.

An alternative possibility is that the viruswhether natural, man-made, or otherwise modifiedleaked from a lab at the Wuhan Institute of Virology (WIV) or another Wuhan-based facility.

In 2015, an article in Journal of Defence Studies profiled the Chinese biological warfare program and noted that the WIV, basically a civilian facility, dealt with certain pathogens, including the SARS virus.In 2019, the WIV was involved in the improper dispatch of highly virulent viruses (not coronaviruses) from Canada to China, which bolstered that case. In January 2020, the WIV was identified as a facility from which SARS-CoV-2 had possibly leaked.

Whether or not the WIVs labs, civilian or otherwise, were holding the COVID-19 virus, it could be an intact natural virus strain. A lab leak might have occurred via an accidentally infected worker, an infected lab animal, or a technical failure.

In February 2020, Maj. Gen. Prof. Wei Chen, a prominent Chinese biological warfare expert affiliated with the militarys Beijing Institute of Biotechnology, was appointed head of the WIV wing, which is at biosafety level 4 (the highest level). In Wuhan, she collaborated with the Wuhan Institute of Biological Products and Wuhan-based academic institutions. Her object was to develop vaccines, anti-sera, and other countermeasures to guard against the spreading COVID-19 virus.

In the US, Prof. Francis Boyle claimed on February 2 that the virus had been held at the WIV as a bioweapon and leaked from its lab. Sen. Tom Cotton amplified the lab virus theory on February 17, when he said the virus might have leaked from the WIV. Concrete evidence beyond the circumstantial was not offered, which discredited the theory.

On the intelligence level, however, evidence was being accumulated that gave credence to the possibility of a Chinese lab leak. On April 5, British intelligence indicated that the features of SARS-CoV-2, as well as the extensive studies conducted in Wuhan on similar coronaviruses, rendered the lab script a credible alternative view. US intelligence officials said there is no evidence the pandemic coronavirus was created in a laboratory as a potential bio-weapon or engineered, but those words do not negate the possibility of a lab leak.

A few days after that statement, nine officials from the current and former US intelligence and national security services who are familiar with the investigations in progress said the possibility that the pandemic was triggered by an accident at a research facility in Wuhan was certainly real and was absolutely under scrutiny at the highest level. Several weeks later, President Trump noted with a high degree of confidence that the outbreak emanated from the WIV, though he added that he could not reveal details.

US Secretary of State Mike Pompeo (who was head of the CIA until April 2018) said that in addition to the WIV, There are multiple labs where the Chinese Communist Party is working on various levels of pathogens. He has also made these statements:

He has also said, however, that The intelligence community is still figuring out precisely where this virus began. We are all trying to figure out the right answer and There are different levels of certainty expressed at different sources of information. Pompeo added that he has no reason to doubt the US intelligence communitys consensus that the virus was not man-made or genetically modified.

A contemporaneous statement from the office of the acting Director of National Intelligence confirmed this, saying the US intelligence community

concurs with the wide scientific consensus that the COVID-19 virus was not a man-made or genetically modified virus. The Community will continue to rigorously examine emerging information and intelligence to determine whether the outbreak began through contact with infected animals (a natural contagion) or if it was the result of an accident at a laboratory in Wuhan.

At about the same time, a preliminary US government analysis compiled from open information said there is no smoking gun to blame the virus on either the Wuhan Institute of Virology or the Wuhan CDC branch, but there is circumstantial evidence to suggest such may be the case while all other possible places have been proven to be highly unlikely.

One US intelligence viewpoint is that there is growing evidence that the virus likely came into being in a Wuhan laboratory, not as a bioweapon but as part of Chinas effort to demonstrate that its ability to identify and combat viruses is equal to or greater than that of the US. Further, a majority of the 17 agencies that provide and analyze intelligence for the US government concurred in May that they believe the pandemic started after the virus leaked from a Wuhan lab, a claim based mostly on circumstantial evidence.

Sen. Tom Cotton, meanwhile, who is a member of the US Senate Select Committee on Intelligence, bolstered his lab leak argument with details based on unclassified general information:

All the evidence at this point points to two labs in Wuhan, while no evidence at all points to the wet market in Wuhan. The fact that they research coronaviruses, that they used bats, that they have a history of bad safety practices, that Patient Zero had no contact with the wet market, all of that is circumstantial evidence to be sure. But in intelligence questions, we rarely get direct or conclusive evidence. So I agree that all of the evidence, albeit circumstantial, points directly at those labs. And if the Chinese Communist Party has evidence to the contrary, they need to bring it forward to the world.

Cotton added, Whether the virus was genetically modified or engineered is a highly technical, scientific question. And the weight of scientific opinion right now [May 5, 2020] says that, no, this was a naturally occurring virus. But a naturally occurring virus can, of course, be present in a laboratory where its being studied.

Statements made afterward by US Assistant to the President Peter Navarro were sharper:

I think personally the virus was spawned in a P4 weapons lab (WIV) The Ground Zero patient in Wuhan was within yards of that P4 lab I think its incumbent on China to prove that it wasnt that lab The Chinese spawned the virus, not created it. That virus was a product of the Chinese Communist Party, and until we get some information about what happened in those labs or what happened in that wet market, we know that the virus was spawned in China. Whether it was purposefully spawned in the Chinese lab is still an open question.

Navarro apparently meant that in a classified military lab of WIV (nominally, and largely in reality, an institute affiliated with the Chinese Academy of Sciences), the Chinese enabled the virus to emerge, whether or not they intended to give rise to the virus that actually came into being. The roles of that lab and the wet market in propelling the initial outbreak remain to be explained. One possibility is that infected animals from the lab were illegally sold in the market. This would fit Navarros description of Patient Zero, who came down with the virus before the market became associated with the contagion.

At any rate, Navarrolike Cottonsaid it is Chinas responsibility to provide evidence of a natural contagion of SARS-CoV-2. As long as China fails to do this, the contagion is to be regarded as unnatural.

In late June, an unclassified report by the US State Department referred to Chinas biological warfare program at large, stating:

The United States does not have sufficient information to determine whether China eliminated its assessed biological warfare program, as required under Article II of the Convention [Chinassubmissions to the convention] have neither documented that offensive program, nor documented that Chinahas eliminated the program or any remaining biological weapons [as required under the accord].

British military and intelligence expert Col. (ret.) Richard Kemp said he had been told by an unnamed insider that there was a very high probability that SARS-CoV-2 was released unintentionally from a Wuhan lab and was a man-made variation. He said he was tipped off about a warfare facility near Wuhan by a senior foreign intelligence source who said analysts strongly suspected Chinas WIV.

Kemp added,

It is very likely to be the case. I was also led to believe governments were very unlikely to come out and say it outright, but that China had been made aware that intelligence agencies had significant evidence. The virus came from an animal that had been involved in testing in the WIV, and had ended up in the wet market. It was believed then and now that an unscrupulous member of staff sold it for personal profit without considering it may be infected. That is how it got out a postulation known to be true but [that] cannot be backed up by absolute evidence.

While this report was highly informative, it has not been verified or refuted.

Australian PM Scott Morrison declined on April 30 to buy into the lab theory, stating that he had not seen anything that suggests that conclusively, while virus emergence from [the] Wuhan wet market appears more likely. Other voices in the Australian government held that it would be unwise to rule out the possibility of the lab scenario. Australian Chair of the Parliamentary Joint Committee on Intelligence and Security Andrew Hastie was diplomatic on the question: I think there are a lot of contentions, and all of them deserve to have a serious consideration. We have to be open-minded about all possibilities.

The specific evidence obtained by the US intelligence community has not been revealed in detail. More concrete intelligence information is generally given a higher classification as it is inadvisable to disclose classified intelligence that could give the opponent room for maneuver. This means there is a sort of Catch-22 between the persuasiveness of evidence and the intelligence communitys freedom to publicize it. This would certainly apply to evidence proving the unnatural origin and source of COVID-19. In any event, it is hoped that a critical mass of convincing information will soon be reached and brought out in detail.

Possible intelligence footholds could ultimately prove to be a key to answering the big questions. A variety of firms and scientific institutions, mainly in the US, Canada, France, Australia, and Singapore, have been collaborating with the WIV (as well as other bio-labs engaged with coronaviruses in Wuhan). The British intelligence community also likely still maintains significant ties in Hong Kong. With that said, it is by no means assured that all those potential intelligence footholds are willing to fully cooperate with intelligence collectors and forward information, either documented or undocumented.

There is a similar challenge regarding the full sharing of intelligence within NATOs Joint Intelligence, Surveillance and Reconnaissance system, as well as within the Five Eyes intelligence community (the US, Britain, Canada, Australia, and New Zealand). Taiwan, India, South Korea, and Japan might also collect valuable information due to their proximity to and interfaces with China.

Former US presidential adviser Steve Bannon revealed on July 13 that They dont speak with the press yet, but there are people from Wuhans laboratory and from other laboratories who have come to the West and are wrapping up evidence in favor of the Chinese Communist Party. I think people will be shocked. According to him, lab staff have been leaving China and Hong Kong since mid-February and certain defectors are working with the FBI to figure out what happened at Wuhans laboratory. US intelligence, in conjunction with British counterintelligence, is preparing a lawsuit.

If this broad international intelligence process takes shape optimally, an informational critical mass will likely be reached eventually that either clears or identifies the WIV (or a similar lab) as the origin and source of the pandemic. How much of that information will be made public is another issue, considering both its classification and sensitivity and Chinas immense global geostrategic position.

Intelligence is generally proof-free, in scientific and/or juridical terms. Proofs obtained by intelligence systems are certainly desirable and do occur, but substantively, intelligence analysis relies on the tracing and deductive recognition of pertinent evidence, even if circumstantial. At times, this essential characteristic of intelligence analysis can be a great disadvantage, but it is rarely insurmountable.

A proper intelligence estimate will always say There are indicative or indirect data pointing to X rather than There is no proof or hard evidence of X. Broadly speaking, any analytical context that is not merely technical but relies on deduction might ultimately reach the point that evidence, even if circumstantial, allows a solid pragmatic conclusion to be drawn. These assessments are considered valid due to their plausibility, even those that are inferential.

In the case of the origin of the COVID-19 pandemic, because of geopolitical considerations and constraints, this approach will probably not suffice to reach a clear-cut conclusion one way or the other.

Intelligence communities can produce (if not autonomously) scientific judgments as well. The scientific dimension related to SARS-CoV-2 is no less complex, in its way, than the intelligence one. Within the scientific dimension polarity prevails, at least for now.

On one side is the concept that both the origin and the source of SARS-CoV-2 are completely natural, and on the other is the idea that its origin was an engineered virus (whether designed as a bioweapon or for other purposes). Between those two polar concepts lies a wide range of variations and combinations, since viral affinities toward humans (which are exceptional in the case of SARS-CoV-2) can be attained or enhanced in different ways. One hypothesis is that the origin of COVID-19 was a manipulated virus, which, if true, is probably technically unprovable.

Be that as it may, synthetic virology and genetic engineering are not the only ways humans can manipulate the evolutionary course of viruses. It could be that a wild-type virus underwent a spontaneous genetic drift after being administered to or seeded in experimental animals or tissue cultures. This would constitute human intervention or manipulation even though it is neither synthesis nor engineering.

A man-made virus literally means it is wholly synthetic, but there are variations on the term man-made like partly synthesized, hybrid, recombinant, mutant, and so on, all of which are artificial and preplanned. Often, too, evolutionary processes leading to similar viruses take place spontaneously in viruses due to man-induced courses in a lab. Chinese biotechnology has mastered both modes of virus handling.

Two recent scientific observations might be highly significant. One is that humans are not yet clever enough to create a virus as sophisticated as SARS-CoV-2, which means it evolved endogenously within an animal or a tissue culture. The other is that certain components of the virus suggest an interaction with a host immune system, which means it could not have formed solely within a tissue culture. If this is true, the implication is that the virus came into being in an animal, either in nature or in a lab.

One possibility, then, is that a wild-type virus was first propagated repeatedly in human tissue cultures, and the resulting spontaneously upgraded virus was subsequently used to experimentally infect monkeys or ferretsone of which then accidentally infected a person in the lab. (The WIV has long been routinely supplied with rhesus monkeys from the Macaque Breeding Base in Suizhou City.)

It is also possible that a wild-type virus became highly human-adapted through a fully natural genetic process that has not yet been pinpointed, and that it infected a person (either through natural contagion or in a lab where it was held). The probability of such a specific adaptational genetic shift taking place completely in nature has been questioned, though various scientific analyses do rely on it.

There is also always the chance that a wild-type strain that would unequivocally demonstrate natural evolution has not yet been isolated from an animal, or has been isolated but not yet sequenced, or has been sequenced but not published. The point is whether or not the existing genomic data relating to coronaviruses at large are sufficiently representative to be relied on for comparative phylogenetic analyses of the pandemic virus in order to determine whether the genomic difference between the pandemic virus and other coronaviruses is an outcome of a natural evolutionary process or of a non-natural, human-induced technical process.

There have also been observations that the extent (rather than the content) of the genetic shift undergone by the pandemic virus prior to its emergence is discordant with the regular spontaneous course of the natural evolutionary clock.

The timing of Patient Zeros infection and subsequent presentation with the disease is a medical matter, but intelligence can play a role here. For example, information could emerge that verifies that on a certain date a technical mishap occurred in a lab while scientists or technicians were handling monkeys that were infected by a virulent, SARS-like coronavirus. Information could also be gathered that on a certain date a lab technician got ill and was later diagnosed as Patient Zero. Such information may, indeed, have already been obtained and corroborated.

Alternatively, it is conceivable that Patient Zero contracted the virus (or a closely related precursor virus) in a bat cave in Yunnan province and then returned, asymptomatic, to Wuhan. If that is the case, an intermediate animal host species between bat and man is not evolutionarily essential. Still, the fact that nothing of the kind has been reported by China appears to imply that it did not take place.

One hypothesis that might be significant is that the progenitor strain of SARS-CoV-2 was a virus that infected six miners in Mojiang, Yunnan Province in 2012. The mine in which they contracted their illness is known to be a breeding ground of bats infected abundantly with assorted coronaviruses. The virus killed three of the six infected miners.

The virus was isolated at the WIV from specimens taken from the infected miners, as discovered recently by Dr.Jonathan Latham and Dr. Allison Wilson. The details are contained in an unremarkable Chinese masters thesis called Analysis of Six Patients with Severe Pneumonia Caused by Unknown Viruses from Kunming Medical University.

According to the hypothesis of Latham and Wilson, the crucial genetic human-adapted shift the virus underwent (or a major part of it) took place during the infection of one or more of the miners. This shift could have continued while the isolated virus was being investigated at the WIV, prior to the initial COVID-19 outbreak and/or during the infection of Patient Zero in Wuhan. This scenario is consistent with the lab leak theory, whether the virus partially evolved in the WIV or not.

The origin and source of the SARS-CoV-2 virus are still a puzzle, and they need to be explained. The World Health Organization said on July 7:

WHO experts will travel to China to work together with their Chinese counterparts to prepare scientific plans for identifying the zoonotic source of the SARS-CoV-2 virus. The experts will develop the scope and TOR for a WHO-led international mission. Identifying the origin of emerging viral disease has proven complex in past epidemics in different countries. A well planned series of scientific researches will advance the understanding of animal reservoirs and the route of transmission to humans. The process is an evolving endeavor which may lead to further international scientific research and collaboration globally.

Zoonotic refers to an infected animal source, including lab animals.

The WHO system responsible for gathering information about emerging and spreading pathogens worldwide is called Epidemic Intelligence from Open Sources. It remains to be seen how far the WHO investigative mission to China will go (if at all) beyond obtaining open information. It is to be hoped that the mission will conduct a comprehensive, vigorous, and objective investigation and will ignore whatever pressures it might face.

Two WHO experts have gone to China as a first step. Executive director of the WHO Health Emergencies Program Mike Ryan underlined that figuring out the true source of the virus requires detective work that will entail an integrated approach and a lot of hard work.

There are important common denominators between intelligence and science, two paramount spheres that are fundamentally different in both essence and substance. A merging of these spheres would be immensely complicated. They are better used to complement one another. The lines between them are often subtle, with a degree of overlap. It is very much to be hoped that they will be able to work together constructively to reach a critical mass of information on the origin and source of COVID-19.

View PDF

Lt. Col. (res.) Dr. Dany Shoham, a microbiologist and an expert on chemical and biological warfare in the Middle East, is a senior research associate at the Begin-Sadat Center for Strategic Studies. He is a former senior intelligence analyst in the IDF and the Israeli Defense Ministry.

Go here to see the original:

Where Did COVID-19 Really Come From? - besacenter.org

Trending Now: Molecular Scissors Technology Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2026| Cibus, Thermo Fisher…

LOS ANGELES, United States: QY Research has recently published a report, titled Global Molecular Scissors Technology Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application. The research report gives the potential headway openings that prevails in the global market. The report is amalgamated depending on research procured from primary and secondary information. The global Molecular Scissors Technology market is relied upon to develop generously and succeed in volume and value during the predicted time period. Moreover, the report gives nitty gritty data on different manufacturers, region, and products which are important to totally understanding the market.

Key Companies/Manufacturers operating in the global Molecular Scissors Technology market include: Cibus, Thermo Fisher Scientific, Inc., Merck, Recombinetics, Sangamo Therapeutics, Editas Medicine, Precision BioSciences, Intellia Therapeutics, Inc., Caribou Biosciences, Inc, Cellectis

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1674037/global-molecular-scissors-technology-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Molecular Scissors Technology market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Molecular Scissors Technology Market Segment By Type:

Cas9TALENs and MegaTALsZFNOthers

Global Molecular Scissors Technology Market Segment By Application:

Cell Line EngineeringAnimal Genetic EngineeringPlant Genetic EngineeringOthers

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Molecular Scissors Technology market.

Key companies operating in the global Molecular Scissors Technology market include Cibus, Thermo Fisher Scientific, Inc., Merck, Recombinetics, Sangamo Therapeutics, Editas Medicine, Precision BioSciences, Intellia Therapeutics, Inc., Caribou Biosciences, Inc, Cellectis

Key questions answered in the report:

For Discount, Customization in the Report: https://www.qyresearch.com/customize-request/form/1674037/global-molecular-scissors-technology-market

TOC

1 Market Overview of Molecular Scissors Technology1.1 Molecular Scissors Technology Market Overview1.1.1 Molecular Scissors Technology Product Scope1.1.2 Market Status and Outlook1.2 Global Molecular Scissors Technology Market Size Overview by Region 2015 VS 2020 VS 20261.3 Global Molecular Scissors Technology Market Size by Region (2015-2026)1.4 Global Molecular Scissors Technology Historic Market Size by Region (2015-2020)1.5 Global Molecular Scissors Technology Market Size Forecast by Region (2021-2026)1.6 Key Regions Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.1 North America Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.2 Europe Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.3 China Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.4 Rest of Asia Pacific Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.5 Latin America Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.6.6 Middle East & Africa Molecular Scissors Technology Market Size YoY Growth (2015-2026)1.7 Coronavirus Disease 2019 (Covid-19): Molecular Scissors Technology Industry Impact1.7.1 How the Covid-19 is Affecting the Molecular Scissors Technology Industry

1.7.1.1 Molecular Scissors Technology Business Impact Assessment Covid-19

1.7.1.2 Supply Chain Challenges

1.7.1.3 COVID-19s Impact On Crude Oil and Refined Products1.7.2 Market Trends and Molecular Scissors Technology Potential Opportunities in the COVID-19 Landscape1.7.3 Measures / Proposal against Covid-19

1.7.3.1 Government Measures to Combat Covid-19 Impact

1.7.3.2 Proposal for Molecular Scissors Technology Players to Combat Covid-19 Impact 2 Molecular Scissors Technology Market Overview by Type2.1 Global Molecular Scissors Technology Market Size by Type: 2015 VS 2020 VS 20262.2 Global Molecular Scissors Technology Historic Market Size by Type (2015-2020)2.3 Global Molecular Scissors Technology Forecasted Market Size by Type (2021-2026)2.4 Cas92.5 TALENs and MegaTALs2.6 ZFN2.7 Others 3 Molecular Scissors Technology Market Overview by Type3.1 Global Molecular Scissors Technology Market Size by Application: 2015 VS 2020 VS 20263.2 Global Molecular Scissors Technology Historic Market Size by Application (2015-2020)3.3 Global Molecular Scissors Technology Forecasted Market Size by Application (2021-2026)3.4 Cell Line Engineering3.5 Animal Genetic Engineering3.6 Plant Genetic Engineering3.7 Others 4 Global Molecular Scissors Technology Competition Analysis by Players4.1 Global Molecular Scissors Technology Market Size (Million US$) by Players (2015-2020)4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Scissors Technology as of 2019)4.3 Date of Key Manufacturers Enter into Molecular Scissors Technology Market4.4 Global Top Players Molecular Scissors Technology Headquarters and Area Served4.5 Key Players Molecular Scissors Technology Product Solution and Service4.6 Competitive Status4.6.1 Molecular Scissors Technology Market Concentration Rate4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data5.1 Cibus5.1.1 Cibus Profile5.1.2 Cibus Main Business and Companys Total Revenue5.1.3 Cibus Products, Services and Solutions5.1.4 Cibus Revenue (US$ Million) (2015-2020)5.1.5 Cibus Recent Developments5.2 Thermo Fisher Scientific, Inc.5.2.1 Thermo Fisher Scientific, Inc. Profile5.2.2 Thermo Fisher Scientific, Inc. Main Business and Companys Total Revenue5.2.3 Thermo Fisher Scientific, Inc. Products, Services and Solutions5.2.4 Thermo Fisher Scientific, Inc. Revenue (US$ Million) (2015-2020)5.2.5 Thermo Fisher Scientific, Inc. Recent Developments5.3 Merck5.5.1 Merck Profile5.3.2 Merck Main Business and Companys Total Revenue5.3.3 Merck Products, Services and Solutions5.3.4 Merck Revenue (US$ Million) (2015-2020)5.3.5 Recombinetics Recent Developments5.4 Recombinetics5.4.1 Recombinetics Profile5.4.2 Recombinetics Main Business and Companys Total Revenue5.4.3 Recombinetics Products, Services and Solutions5.4.4 Recombinetics Revenue (US$ Million) (2015-2020)5.4.5 Recombinetics Recent Developments5.5 Sangamo Therapeutics5.5.1 Sangamo Therapeutics Profile5.5.2 Sangamo Therapeutics Main Business and Companys Total Revenue5.5.3 Sangamo Therapeutics Products, Services and Solutions5.5.4 Sangamo Therapeutics Revenue (US$ Million) (2015-2020)5.5.5 Sangamo Therapeutics Recent Developments5.6 Editas Medicine5.6.1 Editas Medicine Profile5.6.2 Editas Medicine Main Business and Companys Total Revenue5.6.3 Editas Medicine Products, Services and Solutions5.6.4 Editas Medicine Revenue (US$ Million) (2015-2020)5.6.5 Editas Medicine Recent Developments5.7 Precision BioSciences5.7.1 Precision BioSciences Profile5.7.2 Precision BioSciences Main Business and Companys Total Revenue5.7.3 Precision BioSciences Products, Services and Solutions5.7.4 Precision BioSciences Revenue (US$ Million) (2015-2020)5.7.5 Precision BioSciences Recent Developments5.8 Intellia Therapeutics, Inc.5.8.1 Intellia Therapeutics, Inc. Profile5.8.2 Intellia Therapeutics, Inc. Main Business and Companys Total Revenue5.8.3 Intellia Therapeutics, Inc. Products, Services and Solutions5.8.4 Intellia Therapeutics, Inc. Revenue (US$ Million) (2015-2020)5.8.5 Intellia Therapeutics, Inc. Recent Developments5.9 Caribou Biosciences, Inc5.9.1 Caribou Biosciences, Inc Profile5.9.2 Caribou Biosciences, Inc Main Business and Companys Total Revenue5.9.3 Caribou Biosciences, Inc Products, Services and Solutions5.9.4 Caribou Biosciences, Inc Revenue (US$ Million) (2015-2020)5.9.5 Caribou Biosciences, Inc Recent Developments5.10 Cellectis5.10.1 Cellectis Profile5.10.2 Cellectis Main Business and Companys Total Revenue5.10.3 Cellectis Products, Services and Solutions5.10.4 Cellectis Revenue (US$ Million) (2015-2020)5.10.5 Cellectis Recent Developments 6 North America Molecular Scissors Technology by Players and by Application6.1 North America Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)6.2 North America Molecular Scissors Technology Market Size by Application (2015-2020) 7 Europe Molecular Scissors Technology by Players and by Application7.1 Europe Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)7.2 Europe Molecular Scissors Technology Market Size by Application (2015-2020) 8 China Molecular Scissors Technology by Players and by Application8.1 China Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)8.2 China Molecular Scissors Technology Market Size by Application (2015-2020) 9 Rest of Asia Pacific Molecular Scissors Technology by Players and by Application9.1 Rest of Asia Pacific Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)9.2 Rest of Asia Pacific Molecular Scissors Technology Market Size by Application (2015-2020) 10 Latin America Molecular Scissors Technology by Players and by Application10.1 Latin America Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)10.2 Latin America Molecular Scissors Technology Market Size by Application (2015-2020) 11 Middle East & Africa Molecular Scissors Technology by Players and by Application11.1 Middle East & Africa Molecular Scissors Technology Market Size and Market Share by Players (2015-2020)11.2 Middle East & Africa Molecular Scissors Technology Market Size by Application (2015-2020) 12 Molecular Scissors Technology Market Dynamics12.1 Industry Trends12.2 Market Drivers12.3 Market Challenges12.4 Porters Five Forces Analysis 13 Research Finding /Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Disclaimer14.4 Author List

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Excerpt from:

Trending Now: Molecular Scissors Technology Market Detailed Analysis of Current Industry Figures With Forecasts Growth by 2026| Cibus, Thermo Fisher...

Longer Looks: Interesting Reads You Might Have Missed – Kaiser Health News

Each week, KHN finds longer stories for you to sit back and enjoy. This week's selections include stories on COVID, eating disorders, PTSD, the art of play, mosquitoes and more.

Politico:Can America Benefit From Covid? Ask 14th-Century FlorenceThe Covid pandemic has wreaked havoc on the U.S. economy. Around 33 million unemployment claims have been made, and hunger stalks millions more Americansand thats aside from the ravages from the disease itself.Yet big disruptions can bring big opportunities. Thinkers have already been considering how the world could emerge better, or smarter, from the Covid plague. And theres real historical precedent for this: The Italian Renaissance may have begun before the 14th-century plague known as the Black Death, but theres a strong case the diseasein both its ravages and the social changes it enabledhelped accelerate its progress, especially in the city of Florence. For a time, Florences economy bounced back with remarkable social mobility, and it became Europes premier center of artistic, cultural and scientific creativity. (Soll, 7/25)

Politico:How Covid-19 Could Give Kim Jong Un A Doomsday WeaponNorth Korea recently surprised the world by announcing it is developing a Covid-19 vaccine, joining a high-stakes race to show off its scientific chops. But experts increasingly believe the famously secretive Kim Jong Un could also have a more nefarious goal in mind: Using the humanitarian crisis to beef up his biological weapons arsenal. North Korea could use this legitimate vaccine aspiration as a way to enhance their biotechnology capability, says Andrew Weber, who was assistant secretary of Defense for nuclear, chemical and biological defense programs during the Obama administration. They could buy equipment from Western or Chinese sources that would be necessary for their vaccine effort, and then next year they could turn around and use it to produce biological weapons. (Ralph, 7/28)

The Wall Street Journal:Foods That Battle Stress During The Coronavirus PandemicAre you anxious? Angry? Feeling depressed?Consider what you eat. For more than a decade, studies have shown that a healthy diethigh in fruits, vegetables, whole grains, fish and other lean proteincan help fight depression. Now, emerging research in the nascent field of nutritional psychiatry suggests that certain foods can help manage a broader range of emotional challenges, such as anxiety, anger and insomnia. And while the most established treatments for mental-health conditions such as depression remain antidepressants and talk therapy, researchers say food can also be a very useful tool. (Bernstein, 7/27)

The Washington Post:Covid-19 Lockdown Nostalgia: It Was A Scary Time, But I Will Miss Our Enforced Family Togetherness.I sent a text to an old college friend in April, inquiring how she was faring under the covid-19 stay-at-home order then in place, and I confided in her that Id be sad to see it end. I liked that everything had slowed down, that for a brief time, Id stepped off the conveyor belt Id been on that made my life feel less meaningful. My friend, a 57-year-old writer in New York, wrote back immediately: Wow. Will not be sad when its over. Its a dark cloud hanging over life, and I feel panicked and dread for people in the restaurant industry, tourism, etc., and the domino effect that will have on us all." (Chesler, 7/26)

The New York Times:I Was A Screen Time Expert. Then The Coronavirus Happened.Before the pandemic, I was a parenting expert. It was a cushy gig. In 2019, I boarded 34 flights. I checked into nice hotels, put on makeup and fitted jewel-toned dresses, strode onto stages large and dinky, and tried to project authoritative calm. I told worried parents about the nine signs of tech overuse, like ditching sleep for screens. I advised them to write a family media contract and trust, but verify, their tweens doings online. While I was on the road, my two daughters were enjoying modest, cute little doses of Peppa Pig and Roblox, in between happily attending school, preschool, after-school activities and play dates, safe in the care of their father, grandmother and our full-time nanny. Now, like Socrates, I know better. I know that I know nothing. (Kamenetz, 7/27)

And other good reads

The New York Times:With Eating Disorders, Looks Can Be DeceivingAppearances, as Im sure you know, can be deceiving. In one all-too-common example, adolescents and young adults with disordered eating habits or outright eating disorders often go unrecognized by both parents and physicians because their appearance defies common beliefs: they dont look like they have an eating problem. One such belief is that people with anorexia always look scrawny and malnourished when in fact they may be of normal weight or even overweight, according to recent research at the University of California, San Francisco. (Brody, 7/27)

The New York Times:Me, My Relationship And PTSDSam and I began the conversation partly in jest. His co-worker had just eloped in Hawaii, and as we scrolled through their photos I gave him an elbow to the ribs and said in a singsong voice, Well, maybe we should go to Hawaii, too! Later we spoke about it in more thoughtful tones, and as it turned out, neither of us had ever been and we both had always wanted to go to Hawaii. I raised my eyebrows and widened my grin. I think we should do it. Not because its time to get married, I added, loudly. But because we have the perfect opportunity to do it. (Conner, 7/25)

The New York Times:The Way We Used To PlayAs kids, my seven siblings and I would run around outside under the night sky, the summer-hard soles of our bare feet the only shoes we needed, playing a game we made up called War. I grew up as one of a legion of kids living in Cedar Hills, Texas. We were also home schooled, so we were weird, and my world was made up of home and church. But in the evening we would play with the neighborhood kids, the ones with backpacks and clean shoes who waved to us on their way to and from school every day. (Lenz, 7/21)

The Atlantic:The Teaching That Works for Traumatized StudentsWhen Ben started flipping desks in the classroom, his teacher Heather Boyle ushered the rest of her first-grade class into the hallway for safety. Things had begun to unravel a few moments earlier, when Benwhose real name isnt being used, to protect his privacystruggled with a math lesson. He crawled under desks, bumping into other childrens legs. When his classmates complained, Boyle asked him to come out. I dont know how to do this stupid math, he screamed. (McKenna, 7/28)

Arizona Republic:The Navajo Nations Wait For Water Persists With Few AnswersThe line forms at the water spigotbefore dawn. In Chevrolets, Fords and Toyotas, men and women of all ages pull up, the beds of their pickups holding plastic tanks and barrels. Each day, all day long, people wait to take the white hose and let the water run into their tanks. Its the only reliable source of clean drinking water they can count on in this part of the Navajo Nation, and they come from miles around to fill up. (James, 7/28)

The New York Times:Why Some Mosquitoes Prefer HumansMosquitoes have been called the deadliest animal in the world: tiny creatures so dangerous that genetic engineering may be necessary to win the battle against them. But not all mosquitoes are equally responsible for devastating the human population by spreading disease. Out of thousands of species, only a few like to bite humans and even within the same species, mosquitoes from different places can have different preferences. Why do some find us irresistible, while others remain unimpressed? To answer that question, a team of Princeton researchers, working with a large network of local collaborators, spent three years driving around sub-Saharan Africa collecting the eggs of Aedes aegypti mosquitoes, which are responsible for Zika, yellow fever and dengue. (Chen, 7/23)

The rest is here:

Longer Looks: Interesting Reads You Might Have Missed - Kaiser Health News

Stryker (SYK) Q2 Earnings and Revenues Surpass Estimates – Yahoo! Voices

Stryker Corporation SYK reported second-quarter 2020 adjusted earnings per share (EPS) of 64 cents, which beat the Zacks Consensus Estimate of 62 cents by 3.2%. However, the bottom line plunged 67.7% year over year owing to the impact of the COVID-19 pandemic.

The Michigan-based medical device company reported revenues of $2.76 billion, which surpassed the Zacks Consensus Estimate by 5.3%. However, the top line declined 24.3% on a year-over-year basis and 23.5% at constant currency (cc).

Revenues in United States came in at $1.97 billion, down 27.1% year over year. International sales declined 16.4% to $798 million.

Orthopaedic: In the quarter under review, revenues in the segment totaled $894 million, down 29.8% year over year. The segments revenues declined 29.3% at cc. The downside can be attributed to weak performance at the Knees, Hips and Trauma and Extremities sub segments.

Stryker Corporation price-consensus-eps-surprise-chart | Stryker Corporation Quote

MedSurg: This segment reported sales of $1.32 billion, down 17.3% year over year. Sales at the segment decreased 16.4% at cc. Per management, the segment declined 29.3% organically in the reported quarter, owing to weak Instruments, Endoscopy and Medical performances.

Neurotechnology and Spine: Sales in the segment amounted to $546 million, down 29.6% year over year and 28.9% at cc. Organically, the segment witnessed a decline of 29.9%. Per management, the downside was can be attributed to a slowdown in procedures in the second quarter in all the neurotech product lines.

In the second quarter, adjusted gross profit totaled $1.58 billion, down 34.1% from the year-ago quarter. Adjusted gross margin was 57.3%, down 850 basis points (bps).

Adjusted operating income amounted to $345 million, down 63.5% from the prior-year quarter. Adjusted operating margin was 12.5%, down 1340 bps.

Story continues

Cash and cash equivalents came in at $6.54 billion, up 50.8% from the year-end 2019.

Cumulative net cash provided by operating activities in the second quarter were $1.21 billion, reflecting an increase of 46.4% from the year-ago period.

Due to the continued uncertainty surrounding the magnitude and duration of the COVID-19 pandemic, and the uncertain timing of global recovery and economic normalization, the company is unable to project the overall impact on its operations and financial results. Consequently, the company hasnt provided third-quarter or full-year 2020 organic sales or earnings outlook.

Stryker exited second-quarter 2020 on a strong note, with both earnings and revenues surpassing the Zacks Consensus Estimate. However, the company witnessed weak performance across its segments. Decline in international sales was also a dampener.

Moreover, Stryker continues to grapple with pricing pressure. Stiff competition in the MedTech space also remains a concern. Further, contraction in both gross and operating margins in the reported quarter remains a headwind.

Although the second quarter results were negatively affected by the pandemic, the company remains committed to continued advancement of its new product pipelines. Per management, the company is poised to capitalize on the broader resumption of deferrable surgeries.

Stryker currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader medical space are Thermo Fisher Scientific Inc. TMO, PerkinElmer, Inc. PKI and West Pharmaceutical Services, Inc. WST, each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of todays Zacks #1 Rank stocks here.

Thermo Fisher reported second-quarter 2020 adjusted EPS of $3.89, beating the Zacks Consensus Estimate by 45.7%. Revenues of $6.92 billion outpaced the consensus mark by 0.1%.

PerkinElmer reported second-quarter 2020 adjusted EPS of $1.57, surpassing the Zacks Consensus Estimate by 68.8%. Revenues of $811.7 million outpaced the consensus mark by 1.3%.

West Pharmaceuticals reported second-quarter 2020 adjusted EPS of $1.25, outpacing the Zacks Consensus Estimate of 91 cents. Revenues of $527.2 million surpassed the consensus estimate by 6.9%.

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportStryker Corporation (SYK) : Free Stock Analysis ReportPerkinElmer, Inc. (PKI) : Free Stock Analysis ReportThermo Fisher Scientific Inc. (TMO) : Free Stock Analysis ReportWest Pharmaceutical Services, Inc. (WST) : Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment Research

Read more here:

Stryker (SYK) Q2 Earnings and Revenues Surpass Estimates - Yahoo! Voices

Top Shorts In The Last Eight Years That Paid Off Big Time – Yahoo Finance

Its incredibly difficult to make big money shorting stocks. You need a strong conviction in your bets. You need to have a firm belief that something is cooking in the company that most people overlook or choose to ignore. Those shorting stocks during theCOVID-19 pandemichave made more than $50 billion in profits.

Here we take a look at the top shorts of each year between 2013 and 2020. The list is based on data fromActivist Insight Shorts. Josh Black of Activist Insight has given double credit where two short sellers were first and second on the same idea, though their campaign returns might be slightly different.

Short selling is when you bet against astockand profit when it falls. Short sellers borrow shares from investors and then sell them at market price. They expect the stock to decline by a specified future date (the expiration date). If/when the stock tumbles, the short seller buys it back at ridiculously low prices to return to theinvestorfrom whom they had borrowed. The short seller pockets the difference. But sometimes shorting backfires when the stock in question skyrockets.

These are the top shorts between 2013 and 2020 (so far):

Want more short ideas? Check out our upcoming virtual conference with top shortsellers on August 11th.

Short seller The Street Sweeperreleasedan explosive report on Miller Energy Resources in 2011, questioning its accounting practices. The East Tennessee-based oil and gas exploration company slammed the report. Miller CEO Scott Boruff said The Street Sweeper was using deceptive and manipulative tactics to bring down the stock. The Street Sweeper announced in December 2013 that it was shorting Miller Energy. The campaign return stood at a staggering 99.92%. TheSecurities and Exchange Commission(SEC) found that Miller and its executives had "violated the federal securities laws by materially overstating the value of certain oil and gas assets acquired in Alaska on its financial statements."

Apptigo was a technology company engaged in the design and development of smartphone apps. It was the company behind the SCORE match-making app. Short seller GeoInvesting (FG Alpha Management) accused that the company's leadership was engaged in pumping up the stock around the same time Apptigo was hailed as "The #1 Mobile App Tech Stock of 2014." GeoInvesting's short bet gave 99.96% in campaign returns.

Headquartered in Irving, Texas, Adeptus operates free-standing emergency rooms. Short seller Long-Short Value announced in September 2015 that it was shorting the stock. By early 2016, Adeptus had thehighestshort interest among the US-listedstocks. The healthcare companyfiled for Chapter 11 bankruptcyin 2017 amid soaring debt and falling demand. Adeptusemergedfrom the bankruptcy a few months later after completing its financial restructuring. The campaign returned a handsome 98.87%.

Tech Pro Technology is a Hong Kong-based manufacturer of LED lighting products and accessories. In June 2016, GeoInvesting announced that it was shorting the stock. GeoInvesting said at theSohn Conference Hong Kongthat the stock was "grossly overvalued" and "detached from the reality." A little over a month later, Glaucus Research Group announced that it was also shorting Tech Pro Technology. Both short sellers generated about 96.3% in campaign returns.

New York-based Helios and Matheson was a data analytics company. It acquired a controlling stake in MoviePass, a movie subscription service, in 2017. MoviePass was burning cash at an unprecedented pace. The Street Sweeper announced in September 2017 that it was shorting Helios and Matheson. Its shares fell from $38 in October 2017 to $0.21 in July 2018. The company said in January 2020 that it wouldfile for Chapter 7 bankruptcyand liquidate its assets.

Orchids Paper Products is a manufacturer of consumer tissue products. In 2012, Forbes magazine named it among "America's Best Small Companies." The company started facing financial challenges in 2016 due to rising input costs and increasing competition. But the CEO's compensation remainedmuch higherthan the industry average. White Diamond Research announced in December 2018 that it was shorting the stock with 100% downside target. The campaignreturned 99.7%.

Story continues

Helius is a neurotechnology company focused on neurological wellness. In January 2019, White Diamond Researchpublished an articleon Seeking Alpha claiming Helius' only product was an "ineffective device." The short seller also alleged that Helius Medical's founders had "a history of questionable marketing practices." White Diamond evensent a letterto the USFDA, urging them to reject the company's marketing application for the PoNS device. The campaign returned 94.93%.

Luckin Coffee Inc. was hailed as the Starbucks of China. Its growth rate had shocked the Wall Street. In January 2020, Muddy Waters Researchpublished a scathing reportsaying Luckin Coffee was a "broken business" engaged in an accounting fraud. Just days later, J Capital Research confirmed that it was also shorting the stock. When Muddy Waters and J Capital both are shorting a stock, you wouldn't want to be on the other side of the table. After its fraudulent accounting practices came to light, the Chinese company fired its CEO and COO, and Nasdaq halted the trading of its shares.

Want more short ideas? Check out our upcoming virtual conference with top shortsellers on August 11th.

Video: Top 5 Stocks Among Hedge Funds

At Insider Monkey we scour multiple sources to uncover the next great investment idea. We go through lists like the 10most profitable companiesin the world to pick the best large-cap stocks to buy. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. If you want to find out the best healthcare stock to buy right now, you can watch our latesthedge fund manager interview here. You can subscribe to our free enewsletter below to receive our stories in your inbox:

See the article here:

Top Shorts In The Last Eight Years That Paid Off Big Time - Yahoo Finance

Stryker (SYK) to Report Q2 Earnings: What’s in the Cards? – Yahoo Finance

Stryker Corporation SYK is scheduled to release second-quarter 2020 results on Jul 30, after the closing bell. In the last reported quarter, the company delivered earnings surprise of 8.9%. Further, it beat estimates in each of the trailing four quarters, the average surprise being 3.2%.

The Zacks Consensus Estimate for second-quarter earnings per share is pegged at 62 cents, indicating a decline of 68.7% from the year-ago quarter.

The same for revenues stands at $2.63 billion, suggesting a fall of 28.1% from the prior-year quarter.

Strykers MedSurg segment comprises surgical instruments plus endoscopic and emergency medical equipment. It has three subsegments Endoscopy, Instruments and Medical. Unlike first-quarter 2020, which had witnessed partial impact of the COVID-19 pandemic, the second quarter bore the brunt of it. This resulted in the deferral of elective and non-critical procedures.

Consequently, impact of the pandemic is likely to have weighed on the aforementioned subsegments, which in turn might get reflected on MedSurg units second-quarter performance. In fact, the Zacks Consensus Estimate for the segments second-quarter revenues stands at $1.36 billion, suggesting a decline of 15.8% from the year-ago reported figure.

Stryker Corporation price-eps-surprise | Stryker Corporation Quote

Weak performing Knee and Hips sub segment is likely to have weighed on the companys Orthopaedic segment in the second quarter. In fact, the consensus mark for the segments second-quarter revenues stands at $703 million, indicating a plunge of 44.8% prior-year quarter.

With respect to Neurotechnology & Spine segment, weak performance by the NeuroTech and Interventional Spine businesses might have impacted the companys second-quarter performance. For the upcoming quarterly announcement, the Zacks Consensus Estimate for the segments sales stands at $564 million, suggesting a decline of 25.8% from the year-ago quarter.

Nonetheless, sustained strong demand for Mako TKA (Total Knee Arthoplasty) platform or cementless knee and other 3D printed products is anticipated to get reflected in the segments second-quarter performance.

During fourth-quarter 2019, the company acquired Mobius Imaging a leader in point-of-care imaging technology and its sister company Cardan Robotics in an all-cash transaction for $370 million upfront and up to $130 million of contingent payments related to development and commercial milestones. This transaction is likely to have aided Stryker Spine foray into the intra-operative Imaging segment apart from aligning with the companys implant and navigation offering. We expect this development to have positively impacted the companys second-quarter performance.

However, unfavorable pricing may have affected Strykers second-quarter performance. Moreover, high debt might have put pressure on the margins.

Story continues

Per our proven model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is not the case here as you will see.

Earnings ESP: Stryker has an Earnings ESP of -12.58%. You can uncover the best stocks to buy or sell before theyre reported with our Earnings ESP Filter.

Zacks Rank: Stryker carries a Zacks Rank #3.

Here are some medical stocks worth considering as these have the right combination of elements to post an earnings beat this quarter.

Integra LifeSciences Holdings Corporation IART has an Earnings ESP of +20.69% and a Zacks Rank of 2. You can see the complete list of todays Zacks #1 Rank stocks here.

Exact Sciences Corporation EXAS has an Earnings ESP of +6.69% and a Zacks Rank of 2.

Hologic, Inc. HOLX has an Earnings ESP of +14.56% and a Zacks Rank of 3.

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?

Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Dont miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2020 today >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free reportStryker Corporation (SYK) : Free Stock Analysis ReportHologic, Inc. (HOLX) : Free Stock Analysis ReportIntegra LifeSciences Holdings Corporation (IART) : Free Stock Analysis ReportExact Sciences Corporation (EXAS) : Free Stock Analysis ReportTo read this article on Zacks.com click here.

See the original post here:

Stryker (SYK) to Report Q2 Earnings: What's in the Cards? - Yahoo Finance

Life Lived On Screen: Philosophical, Poetic, and Political Observations – lareviewofbooks

AUGUST 2, 2020

I.

THERE IS THE idea of a physical human to human encounter.

As a being together.

The image is one of a shared experience of time a time constituted by the act of committing to one another, to an encounter.

Of inhabiting, together, a space where bodies meet, where talking and laughing and crying is a haptic experience. Where one breathes the same air, smells the same smells.

An experience the body can remember sensorially long after.

Reaching out and touching. Shared surfaces. Breathing, talking, anything really.[1]

Can this kind of encounter happen through machines or machine interfaces? Zoom, Facebook, Google, Twitter, LinkedIn, Skype, Microsoft Teams, and many more.

Can it happen with a machine?

Traditionally, the answer to both questions is no.

No, it cannot really happen by way of a machine interface because too much is lost.

And no, one cannot have a true encounter with machines.

II.

In times of COVID-19, we spend more of our life online in networks than ever before.

What is the effect of this life lived on screen on what it is to be human?

We have more Zoom meetings, surf longer on Instagram, spend more time on Facebook and Twitter than ever before.

What is the transformation of the human brought about by life lived on screens and how to bring this transformation into focus?

As a site of philosophical change and as an opportunity for philosophers, artists, and technologists to come together and give shape?

What are the philosophical and poetic and political stakes and opportunities of this, of our moment in time?

III.

The migration of human activity to technological platforms began long before COVID-19.

The reference, here, is particularly to the emergence in the early 2000s of interactive, often user-generated content, and the emergence of network companies.

The classic examples here are companies like Google (Google mastered microtargeting), Facebook, Twitter, Amazon, Google, Microsoft (Skype and Team), and now also Zoom.

This matters for two reasons.

The first is that the material infrastructural conditions of possibility for how we now spend much of our time has been laid long before the present: satellites, high-speed fiber-optic cables between cities and underneath the ocean, file sharing systems in massive computer farms that host servers, AI algorithms that work through enormous amounts of data quickly to find patterns and calculate preferences, etc.

The second reason is that the material infrastructure that makes life lived on screen possible is inseparably related to platform capitalism. Platform capitalism consists (mostly but not exclusively) of companies that make money by offering free services such as search or posting images or messaging but that collect and harvest user data in order to either sell it to other platform companies or, more often, to sell it to advertising companies (who then devise microtargeting strategies, that is, they deliver ads to specific audiences).

In order to generate data, these companies have been busy finding ways long before COVID-19 to migrate human activity online.

Or, perhaps more accurately: They have been busy creating new forms of human activity suited to life online surfing, search, texting, sexting, browsing, FaceTiming, YouTubing, binge watching, etc.

AR and VR especially via Facebook and Oculus may soon be an additional element of life on screen.

And COVID-19?

Well, for most platform companies, the spread of SARS-CoV-2 and the shelter-at-home orders have been a massive boost: screen time has increased dramatically and so has their capacity to generate and mine data.

That is, COVID-19 has been a consolidation and even an expansion event for platform capitalism.

The contrast to older forms of capitalism, especially to industrial manufacturing, couldnt be sharper.

The question thus emerges whether or not we are currently seeing a powerful acceleration of a shift from earlier forms of capitalism toward a new, still-nascent form called platform capitalism.

A shift from a mode of production focused on the industrial production of goods by labor to another one that is about users, data, and AI?

What are the philosophical, poetic, and political dimension of this shift?

IV.

In my observation, platform companies have made dominant a form of relationality networks that runs diagonal to the usual, place-based socialities of the nation (usually framed in terms of belonging and non-belonging, inclusion and exclusion of a people imagined in territorial and ethnic or racial terms).

In fact, I think it is no exaggeration to argue that networks have given rise to a new structure and experience of reality that is radically different from and even incommensurable with the structure and experience of reality that defined societies.

I offer a simple juxtaposition to illustrate my point.

Societies, usually, have three main features.

First, they are organized hierarchically. That is, they typically have a few powerful individuals at the top, while the vast majority of individuals assemble at the bottom.

Second, they are organized vertically, by which I mean that they accommodate an often vast diversity of opinions and points of views.

Third, societies are usually held together by a national sentiment and, most importantly, by a national communication or media system. The form this media system almost always takes is mass communication, where the few communicate to the many. What they communicate is information information people may vehemently disagree about, but the baseline of this disagreement is that people agree about the things that they disagree about. Mass communication assures that people have a shared sense of reality.

Networks defy all three of those features.

First, if societies are hierarchical and vertical, then networks are flat and horizontal: networks tend to be self-assemblies of people with similar views and inclinations.

Second, while societies are contained by national territories, networks tend to be global and cut across national boundaries: another way of saying this is that while societies are place-specific units, networks are non-place-specific units.

And third, if in society the few communicate with the many and what they communicate is information, then in networks the many communicate directly unfiltered with the many, and what they communicate is not information but affective (emotional) intensity.

It strikes me as uncontroversial that today more and more humans live in networks and that networks, ultimately, defy the logic of society.

Indeed, the rise of networks has created a situation in which, counter to what the moderns thought, society and the social are not timeless ontological categories that define the human.

On the contrary, they are recent and transitory concepts that have no universal validity for all of humanity or all of human history.

Of course, societas is an ancient concept. However, up until the late 18th century, a societas was a legal and not a national or territorial concept; it referred to those who held legal rights vis--vis the monarch.

Things only changed in the years predating the French Revolution when the argument emerged that the people and not the aristocrats and the grand bourgeoisie who held legal rights vis--vis the king should be the society constitutive of the political entity called France.

The early nation-states, which emerged in the context of the first Industrial Revolution and at a time when several cholera epidemics ravaged Europe, found themselves confronted with the need to know their societies, to know how many people lived on their territory, how many were born, how many died, how many got sick and of what; they had to know how many married and how many divorced.

As political existence and the biological vitality of the national society were understood to be connected, states began to conduct massive surveys to understand how they could reform and advance their societies.

Over time between the 1830s and the 1890s this gave rise to what one could call the logic of the social: the idea that the truth about humans is that they are born in societies and that society will shape them and even determine them. The truth about humans is that they are social, in the sense of societal being: tell me in which segment you were born, and I tell you who you are likely to marry, how many kids you we will have, what your job will be, what you are likely to die of.

The social was discovered as the true ontological ground of the human.

To this day, most normative theories of the human call them anthropology: from Marx via the Frankfurt School to Pierre Bourdieu are based on the idea that society is the true ontological ground of the human.

All our modern political institutions are based on society.

If it is true that networks defy the logic of society, then the social sciences, simply because they take the social for granted as the true logic of the human, will fail to bring the human into view.

What we need, then, is a shift from social anthropology (an anthropology that grounds in the concept of the social) to a network anthropology: a multifaceted study of how networks give rise to humans.

V.

The difference between networks and societies which appears to map onto the difference between platform and industrial capitalism is related to the changing relation between humans and machines brought about by recent advances in AI, specifically in machine learning.

One can say that machine learning technologies are beginning to liberate machines from the narrow industrial concept of what a machine is and that this liberation may have far-reaching consequences for what it means to have an encounter.

Traditionally, there were unbridgeable differences between human and machines.

Partly, because humans have intelligence reason while machines are reducible to mechanism.

Partly because machines have no life, no quality of their own. They are reducible to the engineers who invented them and hence mere tools.

The implication, often, is that there is no will, no interference, no freedom, no opening.

But machine learning and neurotechnology make us reconsider these boundaries between organisms and machines, between humans and mechanisms.

First, the success of artificial neural nets or the basic continuity between neural and mechanical processes suggests that the distinction between the natural and the artificial may perhaps matter much less than we thought.

Second, the emergence of deep learning architectures has led to machines with a mind of their own: they have an agency that is not reducible to the intent of or the program written by the engineer.

The exemplary reference here is a 2016 game of Go, played by a deep learning system named AlphaGo (built by DeepMind, a London-based, Google-owned AI company) against Lee Sedol, an 18-time world champion. Toward the end of Game Two in a Best of Five series, AlphaGo opted for a move move 37 that was highly unusual.

DeepMind later announced that AlphaGo had calculated the odds that an expert human player would have made the same move at 1 in 10,000.

It played the move anyway: as if it judged that a nonhuman move would be better in this case.

Fan Hui, the three-time European Go champion, remarked: Its not a human move. So beautiful. So beautiful.

Wired wrote shortly after the game was over: Move 37 showed that AlphaGo wasnt just regurgitating years of programming or cranking through a brute-force predictive algorithm. It was the moment AlphaGo proved it[s] [] ability to play a beautiful game not just like a person but in a way no person could.[2]

Traditionally, a program that doesnt conform to the intentionality of the engineer was considered faulty. However, contemporary machine learning systems are built to defy to exceed the mind of the engineer: it is expected that the machine brings something to a game, a conversation, a question that the engineers did not and could not possibly provide it with (something nonhuman).

These developments one could call them the liberation of machines from the human or at least from the concept of the machine that up until recently defined the human imagination of what a machine could be are related to the rise of networks.

They are related insofar as in networks, relationality once a human to human prerogative may no longer be limited to human to human encounters anymore.

What effects will the liberation of machines which is constitutive of networks as much as of machines have on what it is to be human?

Or on what it is to be in relation?

VI.

As I see it, what is needed now are philosophical investigations of the new technology that is being built.

Not studies in terms of society, as this would ultimately imply holding on to the old concept of the human as social being.

Nor studies in terms of the human, if that means the defense of the human against the machine.

But rather, collaborative studies conducted jointly by philosophers and artists in collaboration with technologists of how networks and machine learning are challenging old and enabling new, yet to be explored concepts of living together.

All by itself, COVID-19 has little to do with these most far-reaching philosophical transformations brought about by networks and by machine learning.

And yet, COVID-19 brings this transformation into view with sharper clarity than ever before and has led to circumstances due to which this new and different world might come faster than we anticipated.

What will it mean to be together with a machine?

To address this question, we may need a whole new vocabulary of encounters and relations.

[1] From Lauren Lee McCarthy, Later Date, 2020, https://vimeo.com/416588466/bb8762077d.

[2] Cade Metz, What the AI Behind AlphaGo Can Teach Us About Being Human, Wired, May 19, 2016, https://www.wired.com/2016/05/google-alpha-go-ai.

Image Credit: Stills from Lauren Lee McCarthy,Later Date, 2020

Tobias Rees isthe founding Director of the Berggruen Institutes Transformations of the Human Program. He also serves as Reid Hoffman Professor of Humanities at the New School for Social Research and is a Fellow of the Canadian Institute for Advanced Research.

Excerpt from:

Life Lived On Screen: Philosophical, Poetic, and Political Observations - lareviewofbooks

Edited Transcript of SYK.N earnings conference call or presentation 30-Jul-20 8:30pm GMT – Yahoo Finance

Q2 2020 Stryker Corp Earnings Call

KALAMAZOO Jul 31, 2020 (Thomson StreetEvents) -- Edited Transcript of Stryker Corp earnings conference call or presentation Thursday, July 30, 2020 at 8:30:00pm GMT

TEXT version of Transcript

================================================================================

Corporate Participants

================================================================================

* Glenn S. Boehnlein

Stryker Corporation - VP & CFO

* Kevin A. Lobo

Stryker Corporation - Chairman & CEO

* Preston Wells

Stryker Corporation - VP of IR

================================================================================

Conference Call Participants

================================================================================

* David Ryan Lewis

Morgan Stanley, Research Division - MD

* Frederick Allen Wise

Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst

* Joanne Karen Wuensch

Citigroup Inc., Research Division - MD

* Joshua Thomas Jennings

Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

* Kaila Paige Krum

SunTrust Robinson Humphrey, Inc., Research Division - Research Analyst

* Kristen Marie Stewart

Barclays Bank PLC, Research Division - Research Analyst

* Kyle William Rose

Canaccord Genuity Corp., Research Division - Senior Analyst

* Lawrence H. Biegelsen

Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

* Matthew Stephan Miksic

Crdit Suisse AG, Research Division - Senior Research Analyst

* Patrick J. Bartoski

Piper Sandler & Co., Research Division - Research Analyst

* Richard S. Newitter

SVB Leerink LLC, Research Division - MD of Medical Supplies & Devices and Senior Research Analyst

* Robert Adam Hopkins

BofA Merrill Lynch, Research Division - MD of Equity Research

* Robert Justin Marcus

JPMorgan Chase & Co, Research Division - Analyst

* Ryan Benjamin Zimmerman

BTIG, LLC, Research Division - MD & Medical Technology Analyst

Story continues

* Vijay Muniyappa Kumar

Evercore ISI Institutional Equities, Research Division - MD

* Xuyang Li

UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

================================================================================

Presentation

--------------------------------------------------------------------------------

Operator [1]

--------------------------------------------------------------------------------

Welcome to the Second Quarter 2020 Stryker Earnings Call. My name is Michelle, and I will be your operator for today's call. (Operator Instructions) This conference call is being recorded for replay purposes.

Before we begin, I would like to remind you that the discussions during this conference call will include forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company's most recent filings with the SEC.

Also, the discussions will include certain non-GAAP financial measures. Reconciliations to the most directly comparable GAAP financial measures can be found in today's press release that is an exhibit to Stryker's current report on Form 8-K filed today with the SEC.

I will now turn the call over to Mr. Kevin Lobo, Chairman and Chief Executive Officer. You may proceed, sir.

--------------------------------------------------------------------------------

Kevin A. Lobo, Stryker Corporation - Chairman & CEO [2]

--------------------------------------------------------------------------------

Welcome to Stryker's second quarter earnings call. Joining me today are Glenn Boehnlein, Stryker's CFO; and Preston Wells, Vice President of Investor Relations. For today's call, I'll provide opening comments, followed by Preston with some perspectives on the recovery trends across our diverse businesses. Glenn will then provide additional details regarding our quarterly results before opening the call to Q&A.

As we begin today's call, I would like to start by thanking all our employees for their continued commitment to ensuring the safety of their colleagues, their families and our customers. I am very pleased with the resiliency of our organization, which has maintained high employee engagement and customer connections through the pandemic: from our sales forces, who have remained present and essential to the doctors and caregivers they support; to our manufacturing teams that have worked around the clock to optimize supply with ever-changing demand; and across our workforce, most of whom continue to collaborate virtually. The Stryker spirit remains alive and well.

Our second quarter sales declined organically by 24%, reflecting the impacts of COVID-19 across all geographies and the majority of our product lines. The results reflect progressive improvement in overall sales through the quarter but do vary by region. The sequential improvement can be tied to the initial cancellation and subsequent gradual return of elective procedures during the quarter.

As mentioned in our first quarter call, we took aggressive steps early on to ensure the safety of our employees and customers while managing discretionary spending across our P&L in response to the slowdown in sales. Our cost containment measures included significant reductions in travel and meetings, a slowdown in hiring and salary reductions across senior leaders. In addition, we made other efforts to focus on cash conservation, including the idling of select product lines and facilities across our network starting in May. These actions, combined with our sales performance resulted in adjusted earnings per share of $0.64, a decline of nearly 68% versus the prior year.

As we look at the quarter, the low point in sales occurred in April and then improved sequentially through the end of June. As a reminder, implants and disposables represent about 75% of our sales and small capital represents 16%. Small capital generally mirrors the performance and trends of implants and disposable. The largest improvements within the quarter were in hips, knees, spine, trauma, sports medicine and Neurotechnology, reflecting the resumption of elective procedures and the gradual opening of previously locked down communities and geographies.

With respect to our large capital businesses, medical capital and Mako were standouts, both posting strong growth for the quarter. Our Mako robotic technology remains in high demand with our customers despite any financial constraints resulting from the pandemic. By geography, Japan and Canada performed well, while Europe, China and Australia showed progressive improvement through the quarter. In contrast, Latin America and India continued to be weaker as the impacts of COVID-19 remain more widespread in those regions. In Q3, we expect the recovery to continue, but do not expect it to be linear while local governments deal with varying degrees of resurgences.

Our R&D programs continue to proceed despite logistical challenges caused by the pandemic, and we spent at a healthy rate in the quarter. We are actively engaging with our customers while ensuring that our product supply is in a strong position to capitalize as procedures resume. However, given the fluid nature of the situation, we are not providing Q3 or full year guidance. We are proceeding with the integration efforts regarding the right medical transaction. We are working cooperatively with the regulators to obtain the necessary approvals for the transaction, including, as previously announced, proposing to divest our STAR total ankle replacement product. This process is well underway, and the U.K. Competition and Markets Authority recently announced that it will consider our proposed undertakings in lieu of a Phase II investigation. We continue to expect to close the transaction around the end of Q3 or beginning of Q4.

Please note, beyond this update, we will not be taking any questions regarding Wright Medical or the pending transaction on today's call. This has been the most unique situation that most of us have ever experienced. While we have been impacted financially as a result of the government shutdowns and deferrals of elective procedures, this time has also allowed us opportunities to reevaluate and develop new ways to work and collaborate across our diverse group of businesses. We are prepared to emerge from the pandemic as stronger, more efficient company. I remain confident in our people, our culture and our ability to partner with our customers to meet the needs of the many patients they serve.

And now over to Preston.

--------------------------------------------------------------------------------

Preston Wells, Stryker Corporation - VP of IR [3]

--------------------------------------------------------------------------------

Thanks, Kevin. My comments today will focus on providing additional insight into the current environment and how certain countries and products performed during the quarter.

We saw progressive improvement in sales throughout the quarter, with April being the low point. The improving trends were primarily driven by the resumption of elective procedures. That momentum is continuing into Q3 as July is trending better than June. We estimate that approximately 40% to 50% of our total global revenue includes procedures that are considered elective or more accurately can be, in many cases, deferred for a period of time. This primarily includes hips and knees, extremities, spine, sports medicine and our ENT business. Geographically, elective procedure recovery varied depending on the government actions and severity of the pandemic.

In addition to the U.S., countries like China, Australia and Germany have also shown month-to-month improvements as elective procedures returned during the quarter, reaching approximately 85% to 90% of pre-COVID levels. The U.K., India and Latin America lagged during the quarter, at less than 50% of pre-COVID levels, as the pandemic continues to spread in these countries.

During the quarter, we saw strong demand for our large capital products, specifically beds and stretchers within our Medical division and ongoing high demand for our Mako robotic technology. In the second quarter, we were very pleased with the Mako installations in the U.S., including increased sales to ASCs and competitive accounts. We continue to see a growing percentage of both hip and knee replacement surgeries being performed with the Mako robot. As it relates to knees, there is an ongoing shift towards cementless. We also launched a new software upgrade for the Mako Hip program that includes features which improve the overall ease of use. Our leadership in orthopedic robotics, a strong order book, and a solid innovation pipeline positions us well to see continued above-market growth in joint replacement.

While we have made meaningful reductions in many discretionary spend items, our investment in R&D remains robust, as does our healthy cadence of new product introductions. During the first half of the year, we are pleased with the customer feedback and results from several new products, some of which include Spine's (inaudible) system, Mini Frag cleaning in Trauma and Neurovascular Vecta 71 and 74 intermediate catheters. These and other launches will contribute to our performance for the rest of the year and position us well for the future.

Although the COVID-19 pandemic has led to a slowdown in elective procedures, it has also placed increased emphasis on the safety of health care providers and their patients. Over the years, we have built an extensive portfolio within our MedSurg businesses, addressing many of the challenges our customers face, with a focus on accident and infection prevention and caregiver safety. This includes products like our patient hygiene and disinfecting products, personal protective equipment, waste management and smoke evacuation devices along with the LUCAS chest compression system which delivers high-quality automated CPR, while reducing the proximity of the caregiver to the patient.

With the ongoing threat of COVID-19 infections, the Department of Defense identified automated compression devices, such as the LUCAS device, as the best practice for delivery of CPR. Demand for these products grew during the quarter in response to these increased safety concerns. We will continue to leverage our diverse portfolio to address changing trends and meet the expectations of our customers, caregivers and patients.

With that, I will now turn the call over to Glenn.

--------------------------------------------------------------------------------

Glenn S. Boehnlein, Stryker Corporation - VP & CFO [4]

--------------------------------------------------------------------------------

Thanks, Preston. Today, I will focus my comments on our second quarter financial results, related drivers and liquidity matters. Our detailed financial results have been provided in today's press release.

Our organic sales decline was 24% in the quarter. These results included a decline in the U.S. of 24 -- 27.4% and an international decline of 14.5%. As a reminder, this quarter included the same number of selling days as compared to Q2 2019. Pricing in the quarter was unfavorable 0.2% from the prior year quarter, and foreign currency had an unfavorable 0.8% impact on sales. During the quarter, our growth was significantly negatively impacted by reductions in elective surgeries, the effects of shelter-in-place orders across many geographies and the pause in hospital capital spending as the medical community navigates this pandemic.

Throughout the quarter, we saw progressive improvement in the expansion of elective surgeries across many geographies which resulted in significant variability in our sales. On an overall basis, our sales decline ranged from minus 36% in April to minus 10% in June.

Our adjusted quarterly EPS of $0.64 represents a decline of 67.7% from Q2 2019. The foreign currency impact on second quarter EPS was minimal. Certain other factors resulted in disproportionately negative impacts on EPS, including the loss of higher-margin sales and a loss of leverage related to manufacturing and operational fixed costs. These were partially offset by our strong focus on disciplined cost control within the quarter.

I will now provide some brief comments on segment sales. Orthopaedics had constant currency and organic sales decline of 29.3%. This included a U.S. decline of 28.8%. We saw declines across our hip, knee and trauma businesses. We also saw very strong growth in our Mako business somewhat offset by declines in bone cement. Internationally, Orthopaedics had an organic decline of 30.4%, which reflects the downturn in elective procedures across most geographies.

MedSurg had constant currency decline of 16.4% and an organic sales decline of 17%, which included a 22.2% decline in the U.S.

Instruments had U.S. organic sales decline of 38%, driven by power tools, waste management and SurgiCount. This was partially offset by increases in Instruments' PPE products, namely our Flyte helmet and other protective products. As a reminder, Instruments also had a very high comparable in Q2 2019 with 19% growth.

Endoscopy had U.S. organic sales decline of 34.1%. This reflects a slowdown in its video, general surgery, communications and sports medicine businesses.

The Medical division had U.S. organic growth of 5.4%, reflecting strong demand across its bed and emergency care businesses, resulting from demand tied to COVID-19, which was offset by declines in Sage related to less patient flow.

Internationally, MedSurg had organic sales growth of 4.6%, reflecting strong demand for medical products in Australia, Canada, Europe and emerging markets.

Neurotechnology and Spine had a constant currency decline of 28.9% and an organic decline of 29.9%. Our U.S. Neurotech business posted a constant currency decline of 36.4% and a 37.5% organic decline for the quarter. This reflects a slowdown in procedures in the quarter related to all our Neurotech businesses. The decline was most pronounced in our ENT, neurosurgical and CMF businesses.

Internationally, neurotechnology and spine had an organic decline of 13%, reflecting slowdowns in Europe, Canada and emerging markets, which was offset by a solid performance in our neurovascular business.

Now I will discuss operating metrics in the quarter. Our adjusted gross margin of 57.3% was unfavorable 850 basis points from the prior year quarter. Compared to the prior year, gross margin was unfavorably impacted by fixed cost absorption and business mix. The fixed cost absorption was significant and related to certain costs associated with idle manufacturing that normally would be capitalized into inventory.

During Q2, we operated at 60% of normal capacity and the related unabsorbed costs diluted our margin by approximately 400 basis points. We anticipate Q3 will be at an average capacity of approximately 85%. Unabsorbed costs will continue to impact our margin until our manufacturing is operating at normal levels. Adjusted R&D spending was 7.6% of sales.

Our adjusted SG&A was 37.1% of sales, which was 360 basis points unfavorable to the prior year quarter. Compared to the prior year, SG&A was unfavorably impacted by business mix and deleveraging of selling and marketing costs, partially offset by operating expense savings actions taken during the quarter.

In summary, for the quarter, our adjusted operating margin was 12.5% of sales. The measures we enacted in March, covering most of our discretionary spending, including curtailments in hiring, travel, meetings and consulting as well as the idling of certain manufacturing lines and facilities, including furloughing the related workers continued throughout the second quarter.

Related to other income and expense as compared to prior year quarter, we saw a decline in investment income earned on deposits and interest expense increases related to increases in our debt outstanding. Our second quarter had an adjusted effective tax rate of 14.4%.

Originally posted here:

Edited Transcript of SYK.N earnings conference call or presentation 30-Jul-20 8:30pm GMT - Yahoo Finance

Trump-loving Texas Rep. Louie Gohmert blames wearing a face mask for his positive COVID-19 test – Salon

Rep. Louie Gohmert, R-Tex., who has publicly scorned face masks and not regularly worn one at work for months, tested positiveWednesday for COVID-19.

The GOP congressman got theresultsat a White House screening ahead of his scheduledflight to Texas that morning with President Donald Trump, CNNreported.

Gohmert attended Attorney General William Barr's testimony before the House Judiciary Committeein person one day earlier. Video footageshows the two men, both maskless, only footsteps apart.

Barr will also get tested for the disease,Department of Justice spokespersonKerr Kupec said Wednesday.

One of Gohmert's own aides asked Politico in an email to include "the fact that Gohmert requires full staff to be in the office, including three interns, so that 'we could be an example to America on how to open up safely.'"

"When probing the office," the aide's email continued, "you might want to ask how often were people berated for notwearing masks."

Gohmert returned to his office after testing positive so that he could break the news to his staff in person, reportedly catching some aides as they were departing.

The eight-term Republican has repeatedly expressed his disdain for facial coverings. He took a break from praising Trump at a White House roundtable in May to preemptively knock reporters in the room, saying the only reason the group would wear a mask was "to protect ourselves from you."

"We had tests, and nobody in here has the coronavirus unless it's somebody in the media," Gohmert said at the time. "So the only reason we would wear masks is if we were trying to protect ourselves from you, in the media, and we're not scared of you."

The Texas lawmaker claimed toCNN in June that he was not wearing a mask on the House floorbecause he wasfrequently tested.

"[I]f I get it," Gohmerttold CNN in June, "you'll never see me without a mask."

CNN reporter Manu Raju on Wednesdayreported thathe had "never seen him wearing a mask on the House floor as he's carried on" with colleagues.

Speaker of the House Nancy Pelosi, D-Calif.,authorizedthe House Sergeant at Arms last month to ban any member who refuses to wear a mask at committee hearingsdays after Rep. Tom Rice, R-S.C., tested positive for COVID-19.

A senior House aide said at the time, "Ultimately, chairs will have the option of not recognizing members in committee proceedings that fail to comply with the mask requirement."

"I'm so sorry for [Gohmert]," Pelositold reporters Wednesday. "But I'm also sorry for my memberswho are concerned, because he has been showing up at meetings without a mask and making a thing of it."

The House speaker told colleagues in a Wednesday call that she would be unveiling a mandatory mask policy for the chamber floor.

Gohmertdid not don a mask ina video statement confirming the reports, which he recorded in his office. He claimed that he wasasymptomatic and would be "very, very careful not to give it to anybody else."

"Reports of my demise are a great deal premature," he said. "I took a quick test, but they get false positives sometimes, so they retested me with the swab that goes way up in your sinuses. It came back positive, too."

"Apparently, I have the Wuhan virus," he said. (The termfor COVID-19, used among some Republicans, has been decried as racist.)

Gohmert added that he had consulted with Sen. Rand Paul, R-Ky., who tested positive for the disease in March. Gohmert said that Paul, the son of physician and former Sen. Ron Paul, assured him that "within 10 days or so, I should be fairly well immune."

The Texan also pushedback against unnamed critics on Twitter.

"I've worn a mask in the last week or two a whole lot more than I have in the last four months," Gohmert asserted.

The congressman also congratulated himself for evading a"fussing" fromJudiciary Chairman JerryNadler, D-N.Y., by wearinga mask during Barr's hearing. However, he omitted his interaction with Barr.

Gohmert also suggested that his mask was to blame for his positive diagnosis.

"I don't know about everybody else, but when I have a mask on, I'm movingit to make it comfortable. And I can't help but wonder if that, you know, puts some germs in the mask," he said. "Keep your hands off the mask."

The blame game was more clearly articulatedduring an interview with local Fox News affiliateKETK-TV.

"I can't help but think that if I hadn't been wearing a mask so much in the last 10 days or soI really wonder if I would've gotten it," Gohmert said."But I know moving the mask around, getting it just right, I'm bound to put some virus on the mask that I sucked in. That's most likely what happened."

But such a suggestion contradicts science. The CDC recommends face coverings as a way to slow the spread of COVID-19.

"Cloth face coverings are most likely to reduce the spread of COVID-19 when they are widely used by people in public settings," the agency says on its website. "The spread of COVID-19 can be reduced when cloth face coverings are used along with otherpreventive measures, includingsocial distancing, frequent handwashing and cleaning and disinfecting frequently touched surfaces."

See the original post:

Trump-loving Texas Rep. Louie Gohmert blames wearing a face mask for his positive COVID-19 test - Salon

Families of those killed by police want autopsies made available. – Los Angeles Times

It is a roster of tragedy and violence, a list populated with those famous in life and those plucked from obscurity by the exceptional circumstances of their death.

Elizabeth Short, known as the Black Dahlia, is an enduring member of the list. Nicole Brown Simpson and Ron Goldman are still there, as is Susan Berman, the writer whom Robert Durst is charged with killing at her Benedict Canyon bungalow. The Notorious B.I.G. was on the list for about 15 years after being killed in a drive-by shooting.

The vast majority are more recent entries, including Andres Guardado, the 18-year-old fatally shot in June by a Los Angeles County sheriffs deputy in Gardena.

These are people whose deaths have been under a so-called security hold by the Los Angeles County medical examiner-coroners office, a status that prevents public disclosure of their autopsies, often for months, years or, in some cases, indefinitely.

At any given time, more than 100 cases are under a security hold. This sealing was considered a routine procedural function, imposed almost always at the request of police or prosecutors, to provide a shroud of secrecy during the investigation of complex, high-profile, mysterious or unusual deaths. Usually, the hold is lifted only when the requesting police or prosecuting agency gives the green light.

But in recent years, the practice has been thrust into the spotlight when on-duty police officers have killed members of the public cases in which anger and skepticism have fueled calls for accountability and transparency, and in which the security hold has only compounded flaring distrust.

The hold has set the coroners office at the center of an impassioned debate that came to a head with the death of Guardado, who was working as a security guard at an auto body shop June 18, when he was approached by officers and ran, his family said. Deputies said Guardado produced a firearm during the chase. His killing spurred days of protests and demands for justice and answers.

After Guardados family publicly shared the results of an independent autopsy, L.A. County Chief Medical Examiner-Coroner Dr. Jonathan Lucas unilaterally bucked the hold installed by the Sheriffs Department and released the full coroners report, confirming that the 18-year-old was shot five times in the back.

Family and friends rally for justice in the case of Andres Guardado, who was fatally shot by a sheriffs deputy in Gardena.

(Jason Armond / Los Angeles Times)

I believe that government can do its part by being more timely and more transparent in sharing information that the public demands and has a right to see, Lucas said in a statement.

Sheriff Alex Villanueva was furious and swiftly rebuked the disclosure, saying it jeopardized the ongoing investigation as well as any future criminal or administrative proceedings, even tainting potential witnesses.

Authorities maintain that security holds are essential for preserving the integrity of cases, and for the families of many homicide victims, the practice has been largely without controversy. The families often form close bonds with detectives or district attorneys and have a greater degree of trust as authorities try to prosecute a killing.

But for the relatives of those killed by police, the security hold is one in a series of ways in which they are treated differently, blocked from officially knowing the details of their loved ones final moments.

Family members speculated it was a way of harassing them, making their loss more difficult because they couldnt have a determination into how their loved one was killed, said Lael Rubin, a retired L.A. County prosecutor who serves on the civilian commission overseeing the Sheriffs Department. She noted cases in which security holds have been in place for two years or longer.

The official word was, We request a security hold for further investigation, but it does seem suspicious, Rubin said. If you havent completed your investigation in two years, what are you doing?

Under state law, coroners reports are public record. The packet is often three reports in one: toxicology tests, an autopsy and an investigative summary. The documents can be incredibly detailed, with a medical history, a listing of prescription drugs the person took and the doctors who issued the pharmaceuticals, descriptions of the persons anatomy and the manner in which they perished.

Photos or videos from a death scene are not released, but a report can include a diagram of a body, along with descriptions of tattoos and piercings.

A hold means the death does not show up in the coroners online database, and staff at the office have limited access to case information, Sarah Ardalani, spokesperson for the Department of Medical Examiner-Coroner, said.

The security hold has become a standard feature in the aftermath of a celebritys death, including singer Whitney Houston, actress and writer Carrie Fisher, actor Paul Walker and the wife of actor Robert Blake. In these cases, the hold prevents salacious tidbits from reaching tabloids and is usually lifted in three to six months, when the full report is complete.

Its main role is to ensure that the facts of the case are held until the investigation can be thoroughly vetted, said Dr. Mark Fajardo, the chief forensic pathologist of Riverside County and former coroner of L.A. County.

Of the 8,000 or so deaths reviewed each year by the L.A. County coroners office, a small fraction are kept secret.

It buys a little time, said Craig Harvey, the longtime chief of investigations for the county coroner, who retired in 2015. Harvey said detectives and prosecutors may consider confidentiality as essential to identifying a suspect who had information that only the killer could know.

For example, LAPD Det. Meghan Aguilar said in a statement, the autopsy report may detail whether the victim was sexually assaulted and whether evidence of this was recovered information that detectives and prosecutors would want to keep a lid on while pursuing a suspect. The autopsy may also reveal if there was a struggle before a person died and what type of injuries on the body would reflect this, Aguilar said.

Why the Simpson and Goldman autopsies remain under a hold is unclear. The LAPD said the 1994 killings are still considered unsolved, warranting the hold, but Judge Lance Ito, who presided over the criminal trial of O.J. Simpson, also appears to have effectively sealed the autopsies. The coroners office confirmed that the autopsies were put on a security hold via court order.

Autopsy reports on Nicole Brown Simpson and Ron Goldman, who were found dead June 12, 1994, in Los Angeles, remain sealed under a court order.

(Associated Press)

It is my recollection this was agreed to by both the prosecution and defense, Ito told The Times via email. Ito, who has retired, declined to explain why he sealed the autopsies, but he noted that photos of the autopsy were displayed and details of the victims cause of death were aired in open court by medical experts.

Security holds might also prevent inflammatory information from reaching the public without proper context; for example, a description of gunshot wounds in a persons back, Harvey said.

Because of the trauma that a bullet does to the body, it doesnt necessarily mean the police shot someone in the back, he said. People may get worked up over something. But it may be explained, and it can make sense, and it can be presented to the grand jury or district attorney.

For more than a year, the family of Paul Rea, 18, waited anxiously to learn more about how he was shot and killed by an L.A. County sheriffs deputy during a routine traffic stop in East L.A.

Prosecutors concluded in May that the deputy acted lawfully, then closed their investigation. Reas family learned this from a Times journalist. Until late last month, the autopsy remained under a security hold.

Grainy security footage that captured part of the June 27, 2019, encounter appears to show Rea breaking from the deputy before he was shot four times. Deputy Hector Saavedra said he felt a gun in Reas waistband, but Rea never pulled it out, according to a report by the district attorneys office.

I want the whole thing. I want to read everything, said Julie Diaz-Martinez, Reas grandmother. As a family member, the autopsy is important, because you wonder, was he still breathing when they took him into the hospital? You wonder, how lethal was the first shot? How long did he suffer? Could it really have been prevented?

A yearlong wait for a security hold to lift is common when people are killed by police, but the hold can stretch on for two years or longer.

Theyre looking for answers about how their loved ones died, and the coroners autopsy often is one of the few repositories of objective information about that, and its hidden from them, said Sean Kennedy, a member of the Sheriff Civilian Oversight Commission. He proposed that the coroner lift holds and make the documents public after a reasonable period of time, perhaps 60 days.

Walter Katz, a former public defender who served as the police watchdog for San Jose and deputy inspector general for the L.A. County Sheriffs Department, said the delays go to the very heart of how those killed by law enforcement are viewed.

They are not treated like victims of a crime. The whole mindset is: Whoever is shot by the police is the suspect, and the law enforcement officer who used force is the victim, Katz said. Thats how the homicide books created by agencies characterize it.

Not every case in which an on-duty police officer fatally shoots a civilian receives a security hold, according to local law enforcement agencies.

LAPD Capt. Gisselle Espinoza said in a statement that security holds are based upon the confidential, legal and the sensitive nature of a case. She cited other factors, including protection of evidence and proper review by the district attorneys office.

If autopsy results are released during an active investigation, it can taint follow-up interviews from victims, witnesses or bystanders, said Jennifer De Prez, a spokeswoman for Long Beach Police Department.

The LAPD has kept a security hold on the autopsy of Melyda Corado for more than two years. Corado was working on July 21, 2018, at the Trader Joes in Silver Lake when Gene Atkins rolled up, hostage in tow, after leading two officers on a lengthy car chase. Atkins stopped the car; ran toward the store, which was crowded with shoppers; and shot at officers. Police returned fire, and one of the bullets struck Corado, killing her.

Mely Corado was not someone engaged with police. She was not a suspect in a crime, said John Taylor, the attorney representing the Corado family in their wrongful-death lawsuit against the city and the LAPD. So to have a security hold on her case has been baffling and confusing.

If theres something thats on the body as evidence that would be known only to the perpetrator of the crime, I can understand, Taylor added.

The L.A. Police Commission has ruled that the officer who fired the shot that killed Corado acted in accordance with LAPD policy. Atkins has been charged under the provocative act murder doctrine for allegedly setting off the events that led to Corados death.

The security hold has remained. Albert Corado, a community organizer who now lives in his late sisters apartment in Atwater Village, said he felt the secrecy was part of a campaign to block information.

Last year, the Corado familys lawyers subpoenaed L.A. County for her autopsy; the coroners office denied their request and referred her family to an LAPD detective, according to court records. The family then successfully persuaded an L.A. County Superior Court judge to order the autopsys release. The city did not oppose the move in court but did not lift the security hold, either.

Albert Corado said he reviewed the report, and it confirmed what he already knew his sister died from a gunshot wound making its secrecy a source of anger and motivation.

The harder they make it to give out information in the run-up to trial is to make you want to give up, he said.

The LAPD told The Times last week that it had directed the investigating officer in the Corado case to remove the security hold. In a statement, the department said the report should be made available to the public this month.

Times staff writers Maloy Moore and Nicole Santa Cruz contributed to this report.

Go here to read the rest:

Families of those killed by police want autopsies made available. - Los Angeles Times

Isaias expected to bring big surf to area beaches – WPRI.com

MIDDLETOWN, R.I. (WPRI) Isaias is still days away from the Ocean State, but local surfers are enjoying the waves before the storm.

Today there were good waves out and got a few good rides in and its going to get better throughout the week, Bret Werner said.

Its getting better Ive heard, so I came down with my friend Bobby and were enjoying the day, Johnny Rodriguez said.

Isaias is expected to pass by Rhode Islands coast late Tuesday night. The storm is bringing heavy rain and wind, creating possible perfect conditions for surfers.

If its safe we will be out here, Werner said.

Possibly yeah, I make take a break tomorrow, but Ill see how Tuesdays going to be, Bob Luongo said.

Bob Luongo has been surfing for fifteen years. The Fall River resident says he checks the wave size and rip currents before going in the water during a storm, but says he has surfed during a hurricane.

I surfed during Hurricane Maria. The storm was out to sea, it wasnt right here, but the waves were really big. Usually theres a lot of people, but the waves were so big there wasnt as many people that day. It was so exciting. It was beautiful, like Heaven on Earth, Luongo said.

The surfers told Eyewitness News, theyre looking forward to the sizable waves.

When a storms out here you get waves like you do in California or Hawaii and like that so everybody does comes out for the waves. Its fun for the ones who know what they are doing, Rodriguez said.

As Isaias continues north, waves along are coast will become much bigger.

Continue reading here:

Isaias expected to bring big surf to area beaches - WPRI.com

North Beach Neighbors Band Together to Boost Restaurants’ Business With Volunteer Deliveries – CBS San Francisco

SAN FRANCISCO (KPIX) Restaurants have been hit hard during the pandemic but one neighborhood in San Francisco is banding together to help and theyre setting an example for the entire Bay Area.

In San Francisco, it is the Italian food that brings people to North Beach. So when the pandemic shut down all the restaurants, residents in the neighborhood saw what a loss it was.

You cant overstate how important they are, said Danny Sauter, president of the North Beach Neighborhood community group. I mean, they give the neighborhood character. We see when one of them leaves, how much of a gap, how much of a hole it leaves in the community.

As restaurants struggled with only curbside sales, private online delivery services were charging them 30 to 40 percent on every order.

Thirty-forty percent eats up everything they got, said North Beach resident Eric Dew. For every pizza pie that they deliver, the restaurant loses money at the end of the day. Thats not acceptable.

So four guys from the neighborhood: Sauter, Dew, Teddy Kramer and Sri Artham got together and formed a group called North Beach Delivers. Each Thursday night since the shelter-in-place began, about 10 volunteers have been delivering meals from a selected restaurant to an area within walking or biking distance. The first restaurant to try it was Piazza Pelegrini on Columbus Avenue.

At first, you know, it felt like a gift from the skies. We definitely needed that, said the restaurants owner, Dario Hadjian.

But then word of the program began to grow and so did the orders.

It really took a few weeks to grow and build up, said Sauter, Now were to the point where, every time we partner with a restaurant, it turns out to be their most successful evening of sales since the pandemic started.

One restaurant, Mister Jius, made $5,000 on one night thanks to North Beach Delivers and some customers have made a regular thing of ordering dinner each Thursday from the latest restaurant of the week featured on the groups website. In the five months since the stay-at-home began, North Beach Delivers has helped generate more than $50,000 in sales for area restaurants.

And now its gotten to the point where weve got a wait list for two months, with restaurants that want to participate, because the impact that we are making is real both financially but also emotionally, said co-founder Teddy Kramer.

North Beach Delivers has inspired some restaurants to set up their own delivery systems and the volunteers say theres no reason the model couldnt be used to help any neighborhood in any city. It just takes people willing to stop feeling bad for restaurants and start doing something to help them.

Were doing everything we can to save every single restaurant in this neighborhood, said Kramer. Our ultimate goal is to build a system that will allow them to live forever.

WEBLINK: North Beach Delivers

Original post:

North Beach Neighbors Band Together to Boost Restaurants' Business With Volunteer Deliveries - CBS San Francisco

Long Island Beaches Reopen This Weekend After Days Of Shark Sightings – CBS New York

Tri-State Braces For Tropical Storm IsaiasTri-State Area emergency management officials have been closely monitoring the storm for several days, and preparations are now underway for its arrival tomorrow. CBS2's John Dias reports.

New York Weather: Pleasant MondayCBS2's Vanessa Murdock has the latest weather forecast.

Negro League Stadium In Paterson, N.J. Getting New Lease On LifeThis year marks what would be the 100th anniversary of the creation of the Negro baseball leagues, and one bit of history is being restored in New Jersey. CBS2's Steve Overmyer reports

New York Weather: All Eyes On IsaiasCBS2's Vanessa Murdock has the latest on the approaching tropical storm. Here's your 11 p.m. forecast.

SpaceX Crew Dragon Safely Returns To EarthThe capsule splashed down softly in the Gulf of Mexico on Sunday, completing its historic journey to the International Space Station. CBS2's Mark Strassmann reports

NYC Shootings Surpass Total For All Of 2019The situation is getting so dire the Brooklyn borough president and district attorney are calling for more drastic measures to stop the gun violence. CBS2's Hazel Sanchez reports

Mother Of Man Killed In Freeport Boat Accident Speaks To CBS2Police are still investigating what led to two boats colliding, resulting in the death of 25-year-old Jorge Soto and injuries to six others. CBS2's Cory James reports

Tracking Isaias: CBS2 Has The LatestCBS2's Vanessa Murdock has what you need to know about Tropical Storm Isaias as it makes its way up the coast toward the Tri-State Area.

New York Weather: Thunderstorms Possible Into MondayCBS2's Vanessa Murdock is tracking some potentially inclement weather that could impact the Tri-State Area during the overnight hours. Here's your 9 p.m. forecast

N.Y. Continues To Make Good Progress In Battle Against CoronavirusThe state is reporting a new low for hospitalizations and no new deaths in New York City. CBS2's Jessica Moore reports

Will There Be More Coronavirus Relief Out Of Washington?New York Sen. Chuck Schumer is among those fighting for more aid for those out of work due to the pandemic. CBS2's Jessica Moore reports

25-Year-Old Man Killed In Freeport Boat CrashPolice in Nassau County are still investigating what led to the two-boat collision that also injured six other people. CBS2's Dave Carlin reports

Florida Has 1-2 Punch Of ProblemsAlready overrun by the coronavirus pandemic, Florida is also dealing with Tropical Storm Isaias. CBS2's Manuel Bojorquez reports

Tracking Isaias: Vanessa Murdock With The LatestThe tropical storm is expected to threaten the Tri-State Area starting Tuesday.

Police Looking For 5 Men Suspected In Armed Robbery, Home Invasion Against 72-Year-Old Bronx WomanPolice said five men knocked on a 72-year-old woman's door and pushed their way in when she answered.

3 Homeless Men Arrested For Fighting With Knife And Sticks At East Village Park, Police SayThree homeless men were arrested overnight after they were found fighting with a knife and sticks at a park in the East Village.

Nassau County Police Investigating Deadly Freeport Creek Boat Crash; 1 Dead, 6 InjuredSeven people were hospitalized following the huge rescue effort at Cow Meadow Park. A 25-year-old man later died from his injuries. CBS2's Christina Fan reports

New York Weather: CBS2's 8/2 Sunday Afternoon ForecastJohn Elliott is tracking Hurricane Isaias and has the updated forecast for the Tri-State area on CBS2 News This Morning.

New York Weather: CBS2 8/1 Nightly Forecast at 11PMCBS2's Vanessa Murdock has your weather forecast for August 1 at 11 p.m.

President Donald Trump Threatens To Ban TikTokThe social media app TikTok is a favorite for teens -- and a favorite target for President Donald Trump. The president has threatened to ban the platform, but the company says it's not going anywhere; CBS2's Nick Caloway reports.

Decision To Reopen NY Schools Will Be Made In Early August, Cuomo SaysGov. Andrew Cuomo says a decision on schools reopening in New York could be just days away.

7 People Injured When Boats Collide In Freeport, Long IslandSeven people were injured Saturday night after a boat collision in Nassau County that was so violent, one of the boats was split in two; CBS2's Cory James reports.

New York Weather: CBS2 8/1 Evening Forecast at 6PMCBS2's Vanessa Murdock has your weather forecast for August 1 at 6 p.m.

Salmonella Outbreak Linked To Red OnionsThere's a health alert over a salmonella outbreak involving red onions.

See the article here:

Long Island Beaches Reopen This Weekend After Days Of Shark Sightings - CBS New York

Various groups hold beach cleanups across the Coastal Bend area in the aftermath of Hurricane Hanna – KIIITV.com

After Hurricane Hanna took a beating on our coastal environment, many members of the community have stepped up to help restore the area.

CORPUS CHRISTI, Texas Dozens of people showed up to Mustang Island State Park on Saturday morning for a beach cleanup organized by Texas Parks and Wildlife.

Volunteers began at 9 a.m on August 1 and met in the parking lot to receive their gloves and bags for the trash they would be picking up.

Officials say the event was aimed to reduce litter and trash debris from Hurricane Hanna and want to remind the public that the park is not open for recreational access at this time.

Meanwhile, a group of young men from the U.S. Coast Guard Sector Air Station- Corpus Christi worked extremely hard to clean up Doddridge Park in the aftermath of Hurricane Hanna.

Flour Bluff-Padre Island 4-H club also helped clean the Packery Channel on Saturday. According to Flour Bluff-Padre Island 4-H's reporter, Hailey, "Seventeen people come out and help participate in the Hurricane Hanna Packery Channel Park clean up. We were able to pick up quite a bit of trash. Everyone did a great job!"

A group of students from Texas A&M University-Corpus Christi rolled up their sleeves for two days of labor at the Corpus Christi Marina, moving debris caused by Hurricane Hanna.

TAMU-CC officials say the student team was managed by Tony Wood, Director of The National Spill Control School at Texas A&M-Corpus Christi, with approval from Marina Superintendent, Gina Sanchez.

Organizations such as Beach Keepers have also stepped up their efforts in their dedication to keeping area beaches and parks clean.

Beach Keepers also held a beach cleanup near Whitecap Beach on Saturday morning.

The director of Beach Keepers, Lana Rayn, made an early morning trip to Corpus Christi and cleaned up area beaches all day. According to the organization, Rayn lives three hours away from Corpus Christi but has made every beach cleanup.

Beach Keepers is hosting a beach cleanup on Saturday, August 8 from 7:30 a.m. to 10:30 a.m.

Hannas Helpers by Beach Keepers will meet on Mustang Island and volunteers will be formed into teams of 10 or less.

Organizers say Beach Keepers will provide water, bags, and gloves but volunteers must bring their own face mask, hand sanitizer, and other personal protective gear.

For more information on how you can get involved with Hannas Helpers by Beach Keepers, please visit their Facebook page.

Causes event in Corpus Christi, TX by Plastic Planet by Lee Allen and Beach Keepers Hub on Saturday, August 8 2020

Link:

Various groups hold beach cleanups across the Coastal Bend area in the aftermath of Hurricane Hanna - KIIITV.com

Close encounter: mother and calf whales stun surfers at Sydney’s Manly beach – The Guardian

A whale calf, closely followed by its mother, came within metres of surfers and swimmers at Manly beach, in Sydneys north, on Sunday afternoon.

The pair were initially identified as humpbacks by onlookers, but marine wildlife experts later said they were most likely southern rights, which also migrate north to calve, then return to colder waters for the southern summer.

One boardrider, Josh, told Guardian Australia he had never seen a whale, particularly a calf, come so close to the beach at Manly.

There was a bit of pointing going on and I looked round and the little one was just there, Josh said.

Then mum came in pretty quick smart, I think when she realised how close people were.

You often see [whales] further out the back but this one just came right up to where people were hanging on their boards.

Images show dozens of surfers watching from about 10m from the whales.

Initially there was some concern that one of the whales had been caught in a shark net, but surfers said that was not the case.

I think everyone was just paddling up to get a good look. Its the sort of thing you wont forget seeing.

Last week researchers from the University of NSW found that while whale-watching season in Australia is often a tourism drawcard, many were not in optimum health during the return leg of the migration.

The researchers collected and analysed samples of whale blow similar to mucus from a human nose from humpbacks and found significantly less microbial diversity and richness on journey south.

Their paper, published in the journal Scientific Reports, said this indicated the whales were likely in poorer health than when their journey began.

People enjoy whale-watching season, but with it comes reports of whales becoming stranded, said the studys lead author, science researcher Catharina Vendl.

Although humpback whale stranding events occur naturally and regularly to injured and young whales, it is crucial to monitor the population health of this iconic species to ensure its long-term survival.

Humpback whales do not only play an essential role in their marine ecosystem but also represent an important economic resource because whale-watching is a booming industry in many Australian cities and around the world.

This article was amended on 3 August 2020 to correct the identification of the species. It originally said the whales were humpbacks, but marine wildlife experts contacted by Guardian Australia subsequently identified them as more likely to be southern right whales.

Read the original here:

Close encounter: mother and calf whales stun surfers at Sydney's Manly beach - The Guardian

Bitcoin Cash (BCH) Down $2.62 On 4 Hour Chart, in an Uptrend Over Past 14 Days; Price Base in Formation Over Past 90 Days – CFDTrading

Bitcoin Cash 4 Hour Price Update

Updated August 03, 2020 07:20 AM GMT (03:20 AM EST)

Bitcoin Cash came into the current 4 hour candle up 0.77% ($2.23) from the open of the previous 4 hours, marking the 2nd candle in a row it has gone up. On a relative basis, Bitcoin Cash was the worst performer out of all 5 of the assets in the Top Cryptos asset class during the previous 4 hours.

The end of a 3 day positive run has come for Bitcoin Cash, which finished yesterday down 11.33% ($36.25). As for how volume fared, yesterdays volume was up 51.14% from the previous day (Saturday), and up 219.48% from Sunday of the week before. On a relative basis, Bitcoin Cash was the worst performer out of all 5 of the assets in the Top Cryptos asset class during yesterday. Here is a daily price chart of Bitcoin Cash.

Coming into today the current price of Bitcoin Cash is sitting close to its 200 day moving averages; moving average crosses often indicate a change in momentum, so this may be worth keeping an eye on. Trend traders will want to observe that the strongest trend appears on the 14 day horizon; over that time period, price has been moving up. For another vantage point, consider that Bitcoin Cashs price has gone up 6 of the previous 10 trading days.

For laughs, fights, or genuinely useful information, lets see what the most popular tweets pertaining to Bitcoin Cash for the past day were:

Few years ago, people were busy creating hard forks of Bitcoin and we have dozens of clones like Bitcoin Cash, Bitcoin SV, Bitcoin Gold, Bitcoin Private etc. In 2020, we have YFI and people have forked it into YFII, YFFI.

#Crypto Top 5 Vol vs. Circ Supply (24H) by Highest Volume$USDT Tether 39,955.29M of 11,065.83M (361.07%)$BTC Bitcoin 2.39M of 18.45M (12.96%)$ETH Ethereum 43.27M of 112.01M (38.63%)$XRP XRP 13,213.83M of 44,862.65M (29.45%)$BCH Bitcoin Cash 11.25M of 18.48M (60.90%)

Im so glad @jeffreyatucker was part of the Bitcoin Cash Fork Day broadcast. What a great talk by him!

Read this article:

Bitcoin Cash (BCH) Down $2.62 On 4 Hour Chart, in an Uptrend Over Past 14 Days; Price Base in Formation Over Past 90 Days - CFDTrading

Two New Rapid COVID-19 Tests To Be Rolled Out in the UK Ahead of Winter – Technology Networks

Millions of new rapid coronavirus tests will be rolled out across NHS hospitals, care homes and labs from next week.

- Both tests will be able to detect COVID-19 and other winter viruses in just 90 minutes- New tests will hugely increase testing capacity ahead of winter, delivering fast results that will help to break chains of transmission quickly

Millions of ground-breaking rapid coronavirus tests will be rolled out to hospitals, care homes and labs across the UK to increase testing capacity ahead of winter. The tests will enable clinicians and NHS Test and Trace to quickly advise on the best course of action to stop the spread of the virus.

Two new tests both able to detect the virus in just 90 minutes will be made available to NHS hospitals, care homes and labs. The 2 tests will be able to detect both COVID-19 and other winter viruses such as flu and respiratory syncytial virus (RSV). The tests do not require a trained health professional to operate them, meaning they can be rolled out in more non-clinical settings.

This will help to further strengthen the coronavirus response this winter, arming both clinicians and NHS Test and Trace with the ability to distinguish between COVID-19 cases, which have specific self-isolation requirements, and other winter viruses.

Health Secretary Matt Hancock said:"Were using the most innovative technologies available to tackle coronavirus. Millions of new rapid coronavirus tests will provide on-the-spot results in under 90 minutes, helping us to break chains of transmission quickly.The fact these tests can detect flu as well as COVID-19 will be hugely beneficial as we head into winter, so patients can follow the right advice to protect themselves and others. I am hugely grateful for the excellent work done by DnaNudge and Oxford Nanopore to push forward these life-saving innovations in coronavirus testing."

A new test that uses DNA to detect the virus will be rolled out across NHS hospitals from September, with 5,000 DNA machines, supplied by DnaNudge, to provide 5.8 million tests in the coming months.

Separately, 450,000 90-minute LamPORE swab tests will also be available across adult care setting and laboratories from next week, supplied by Oxford Nanopore.DNA testing for coronavirus

5,000 DNA Nudgebox machines, supplied by DnaNudge, will be rolled out across NHS hospitals in the UK to analyse DNA in nose swabs, providing a positive or negative result for COVID-19 in 90 minutes, at the point of care. The machines will process up to 15 tests on the spot each day without the need for a laboratory.

The DNA COVID-19 test machines are currently operating in 8 London hospitals:

- St Marys Hospital in Paddington- Charing Cross Hospital- West Middlesex University Hospital- Chelsea and Westminster Hospital- Royal Hospital Chelsea- Queen Charlottes and Chelsea Maternity Hospital- the Renal Transplant Centre at Hammersmith Hospital- the Tower Hamlets Centre for Mental Health at Mile End Hospital

The machines are located in cancer wards, A&E and maternity wards to protect those most at risk.

The government is signing contracts with more companies to produce machines for DNA coronavirus testing.

Rapid LamPORE tests

The new rapid LamPORE test will be able to process swab and saliva samples to detect the presence of COVID-19 in 60 to 90 minutes.

The new test has the same sensitivity as the widely used PCR swab test, but can be used to process swabs in labs, as well as on-location through pop up labs. The desktop GridION machine can process up to 15,000 tests a day, or the palm-sized MinION can process up to 2,000 tests a day for deployment in a near-community pop-up lab.

450,000 of the new LamPORE tests will be available from next week across adult care settings, NHS laboratories and lighthouse laboratories, with millions more tests to be rolled out later in the year.

Details of positive test results will be shared with NHS Test and Trace, so close contacts can self-isolate in line with guidance.

Regius Professor Chris Toumazou FRS, CEO and co-founder of DnaNudge and founder of the Institute of Biomedical Engineering at Imperial College London, commented: "The DnaNudge team worked with incredible speed and skill during the peak of the pandemic to deliver this highly accurate, rapid COVID-19 test, which requires absolutely no laboratory or pipettes and can be deployed anywhere with a direct sample-to-result in around just over an hour.We have been able to successfully adapt our in-store consumer DNA testing technology which identifies genetic risks for chronic conditions related to obesity and type 2 diabetes and validate it for detecting COVID-19 with gold-standard accuracy.We are extremely proud to be playing such a pivotal role in supporting the national effort on testing, as this major contract award signifies. With the ability to test not only for COVID-19 but also FluA, FluB and RSV on the same single COVID-19 Nudge cartridge, our multiplex test offers a vital solution to protect the NHS as we head into the flu season."

Gordon Sanghera, CEO of Oxford Nanopore, said: "We are honoured to be playing a part in fighting COVID-19 in the UK, and preparing the country for the winter virus season. Ever since we founded Oxford Nanopore, our mission has been to create disruptive, high performance technology that has a profound, positive impact on society.LamPORE has the potential to deliver a highly effective and, crucially, accessible global testing solution, not only for COVID-19 but for a range of other pathogens. We are delighted to be working with the UK government to support and empower our communities to effectively manage testing at a national and localised level."

Background informationAbout DnaNudge

DnaNudge, based in London, is a retail based, on-the-spot genetic testing service that provides product recommendations suited to your DNA to promote a healthy lifestyle.

DnaNudges new RNA COVID-19 tests are based on DnaNudge DNA testing innovation delivering processing outside of a laboratory environment, using DnaNudges patented and miniaturised NudgeBox analyser, which can be used anywhere.

About Oxford Nanopore

Oxford Nanopore, which last year built a factory in Oxfordshire, is a rapidly growing business that is scaling its operations to be able to provide substantial volumes of tests to the UK critical to support expanded testing at a time when global supply chains are squeezed for traditional tests.

About LamPORE

LamPORE uses a method called RT-LAMP to identify and amplify the SARS-CoV-2 virus in an original sample, and Oxford Nanopores sequencing technology to precisely identify the amplified virus. It tests for active infection, providing a complementary testing solution to antibody detection, currently only able to indicate a previous infection.

LamPORE includes a control mechanism that detects and invalidates samples where there has been an error in sample collection.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Continue reading here:
Two New Rapid COVID-19 Tests To Be Rolled Out in the UK Ahead of Winter - Technology Networks